<!--#if expr="$title" --> <!--#echo var="title" --> <!--#else --> HIV Drug Resistance Database <!--#endif -->
Stanford University HIV Drug Resistance Database - A curated public database designed to represent, store, and analyze the divergent forms of data underlying HIV drug resistance.

Genbank References

BLAST search against GenBank file v. V 219.0 released on 2017-04-15
(search results include 357418 sequences from 2853 references)

This page contains a list of all GenBank entries on HIV-1 protease, RT and integrase grouped by reference. The reference may include a published paper or the title provided with the GenBank submission. The purpose of this page is to show which GenBank entries are in the HIV Drug Resistance Database and which aren't. The last column (Annotation) of the table shows whether or not there are plans to add the entry to the database. Each entry in the Annotation column is linked to a page explaining the annotation.

The entries were created by performing a BLAST search of the GenBank using the consensus B protease, RT and integrase amino acid sequence (give link to the sequences). The E-value column contains the lowest e-value (best match) for all the GenBank entries associated with a specific reference. The columns, # in GB, # in HIVDB, and % in HIVDB indicate the number of entries in GenBank associated with the reference, the number of these entries that are also in the HIV Drug Resistance Database, and the % of GenBank entries from a particular reference that are in the HIV Drug Resistance Database.

For a treatment summary for every isolate in our database and in the GenBank, click here. This file indicates whether or not the person from whom the sequenced virus was obtained had received one or more nucleoside RT inhibitor, nonnucleoside RT inhibitor, or protease inhibitor.


 

AuthorsTitleCitationE-value# in HIVDB# in Gb% in HIVDBAnnotation
Abdellaziz (2015) Predominance of CRF06_cpx and transmitted HIV resistance in Algeria: update 2013-2014 AIDS Res. Hum. Retroviruses (2015) In press 0 228
119PR
109RT
230
119PR
111RT
99 HIVDB
Abdissa (2014) Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia BMC Infect. Dis. 14, 181 (2014) 0 28
28PR
28RT
29
29PR
29RT
96 HIVDB
Abdoel Wahid (2016) HIV-1 genetic diversity and drug-resistance mutations among treatment-naive adult patients in Suriname AIDS Res. Hum. Retroviruses (2016) In press 1.42e-176 100
99PR
95RT
100
99PR
95RT
100 HIVDB
Abdool Karim (2016) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Science 329 (5996), 1168-1174 (2010) 0 94
92PR
94RT
94
92PR
94RT
100 HIVDB
Abecasis (2007) RECOMBINATION confounds the early evolutionary history of human immunodeficiency virus type 1: subtype g is a circulating recombinant form J. Virol. 81 (16), 8543-8551 (2007) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Abecasis (2011) Molecular epidemiological analysis of paired pol/env sequences from portuguese HIV-1 patients AIDS Res. Hum. Retroviruses (2011) In press 0  
154
154PR
154RT
0 ARV Rx and/or other data are N/A
Abraha (2016) CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic J. Virol. 83 (11), 5592-5605 (2009) 2.86e-106  
11
11RT
0 Case report(s) / study subset
Acharya (2009) Human immunodeficiency virus type 1 drug resistance mutations in patients from India Unpublished 1e-178  
1
1PR
1RT
0 Case report(s) / study subset
Acharya (2014) Development, Validation and Clinical Evaluation of a Low Cost In-House HIV-1 Drug Resistance Genotyping Assay for Indian Patients PLoS ONE 9 (8), E105790 (2014) 0 206
206PR
206RT
206
206PR
206RT
100 HIVDB
Acharya (2015) Genetic analysis of HIV-1 integrase gene sequences among 1st line treatment experienced patients from India Unpublished 0  
31
31IN
0 Case report(s) / study subset
Achkar (2004) INFECTION with group M non-B HIV-1 subtypes in individuals living in New York City Unpublished 1e-159  
34
34PR
3RT
0 ARV Rx and/or other data are N/A
Adachi (1986) PRODUCTION of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone J. Virol. 59 (2), 284-291 (1986) 1e-165  
1PR
1RT
1IN
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Adojaan (2004) PREDOMINANCE of a Rare Type of HIV-1 in Estonia J. Acquir. Immune Defic. Syndr. 39 (5), 598-605 (2005) 0 4
4PR
4RT
4IN
143
143PR
4RT
4IN
2 HIVDB
Adungo (2016) Genetic Diversity of HIV-1 in Busia, Kenya Unpublished 5.93e-45  
71
71PR
0 Gene fragment(s)
Afonso (2012) HIV-1 Genetic Diversity and Transmitted Drug Resistance Mutations among Patients from the North, Central and South Regions of Angola PLoS ONE 7 (8), E42996 (2012) 2e-178 101
99PR
101RT
101
101PR
101RT
100 HIVDB
Aghokeng (2007) FULL-LENGTH sequence analysis of SIVmus in wild populations of mustached monkeys (Cercopithecus cephus) from Cameroon provides evidence for two co-circulating SIVmus lineages Virology 360 (2), 407-418 (2007) 0 5
3PR
5RT
5IN
5
3PR
5RT
5IN
100 HIVDB
Aghokeng (2009) Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries Antivir. Ther. (Lond.) 14 (3), 401-411 (2009) 0 135
135PR
135RT
135
135PR
135RT
100 HIVDB
Aghokeng (2010) Extensive survey on the prevalence and genetic diversity of SIVs in primate bushmeat provides insights into risks for potential new cross-species transmissions Infect. Genet. Evol. (2009) In press 0  
20
1PR
5RT
20IN
0 NHPL/SIV
Aghokeng (2010) Genetic diversity of simian lentivirus in wild De Brazza's monkeys (Cercopithecus neglectus) in Equatorial Africa J. Gen. Virol. 91 (PT 7), 1810-1816 (2010) 2e-70  
1
1IN
0 NHPL/SIV
Aghokeng (2011) High Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity J. Clin. Microbiol. 49 (4), 1635-1641 (2011) 1e-176 145
145PR
145RT
145
145PR
145RT
100 HIVDB
Aghokeng (2011) Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients AIDS 25 (17), 2183-2188 (2011) 0 85
85PR
85RT
85
85PR
85RT
100 HIVDB
Aghokeng (2013) Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon J Int AIDS Soc 16, 18004 (2013) 0 65
65PR
65RT
65
65PR
65RT
100 HIVDB
Aghokeng (2014) Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia Clin. Infect. Dis. 58 (1), 99-109 (2014) 1.41e-173 170
20PR
170RT
170
20PR
170RT
100 HIVDB
Agneskog (2008) CHANGES in mutation patterns of a mosaic genome HIV-1 strain after treatment with nucleoside analogs and the integrase inhibitor raltegravir Unpublished 1e-173  
8
3PR
6RT
2IN
0 Case report(s) / study subset
Agwale (2003) GENOTYPIC and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive nigerian patients AIDS Res. Hum. Retroviruses 22 (1), 22-26 (2006) 5e-81 18
18PR
18RT
18
18PR
18RT
100 HIVDB
Agwu (2008) Analyses of HIV-1 Drug-Resistance Profiles Among Infected Adolescents Experiencing Delayed Antiretroviral Treatment Switch Following Initial Nonsuppressive Highly Active Antiretroviral Therapy Unpublished 0  
156
156PR
156RT
0 Pending
Agyingi (2014) The Evolution of HIV-1 group M Genetic Variability in Southern Cameroon is characterized by Several Emerging Recombinant Forms of CRF02_AG and viruses with drug resistance mutations Unpublished 0 210
106PR
104RT
214
106PR
108RT
98 HIVDB
Ahuka-Mundeke (2010) Full-length genome sequence of a simian immunodeficiency virus (SIV) infecting a captive agile mangabey (Cercocebus agilis) is closely related to SIVrcm infecting wild red-capped mangabeys (Cercocebus torquatus) in Cameroon. J Gen Virol 0 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Ahuka-Mundeke (2011) Novel Multiplexed HIV/Simian Immunodefi ciency Virus Antibody Detection Assay Emerging Infect. Dis. 17 (12), 2277-2286 (2011) 4e-65  
7
1RT
7IN
0 Gene fragment(s)
Ahumada-Ruiz (2009) Analysis of HIV-1 pol sequences from Panama: identification of phylogenetic clusters within subtype B and detection of antiretroviral drug resistance mutations Infect. Genet. Evol. 9 (5), 933-940 (2009) 0  
136
136PR
136RT
0 Pending
Ait-Khaled (2003) Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy Antivir. Ther. (Lond.) 7 (1), 43-51 (2002) 3.95e-153 156
156RT
156
156RT
100 HIVDB
Ajoge (2011) Drug resistance pattern of HIV type 1 isolates sampled in 2007 from therapy-naive pregnant women in North-Central Nigeria AIDS Res. Hum. Retroviruses 28 (1), 115-118 (2012) 0 56
28PR
28RT
56
28PR
28RT
100 HIVDB
Akapirat (2013) Clinical variables influencing anti-human immunodeficiency virus type 1 neutralizing human monoclonal antibody (NHMAb) production from Thai human immunodeficiency virus type 1-infected individuals Unpublished 6.47e-147  
4
4PR
4RT
0 Case report(s) / study subset
Akouamba (2016) HIV-1 genetic diversity in antenatal cohort, Canada Emerging Infect. Dis. 11 (8), 1230-1234 (2005) 2.01e-120  
103
103RT
0 Gene fragment(s)
Akrim (2012) HIV-1 Subtype distribution in morocco based on national sentinel surveillance data 2004-2005 AIDS Res Ther 9 (1), 5 (2012) 7.68e-151 107
58PR
49RT
107
58PR
49RT
100 HIVDB
Alaoui (2016) Genetic analysis of HIV-1 integrase gene from antiretoviral treatment naive and experienced patients in Morocco Unpublished 0  
155
155IN
0 Unpublished
Albert (1992) PERSISTENCE of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera J. Virol. 66 (9), 5627-5630 (1992) 5e-55  
20
20RT
0 Case report(s) / study subset
Albert (1995) Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes J. Virol. 68 (9), 5918-5924 (1994) 2.97e-141 23
23RT
26
26RT
88 HIVDB
Alcalde (2011) Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinant forms that are circulating in the city of Sao Paulo, Brazil Virol. J. 9, 156 (2012) 0 45
45PR
45RT
249
249PR
249RT
18 HIVDB
Alcalde (2016) Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinants forms which is circulating in Sao Paulo city, Brazil Unpublished 2.82e-169 43
43PR
43RT
44
44PR
44RT
97 HIVDB
Alcantara (2012) HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures J. Clin. Virol. 54 (1), 15-20 (2012) 6.04e-173 76
75PR
76RT
76
75PR
76RT
100 HIVDB
Alcantara (2012) Increasing heterosexual transmission of HIV-1 subtype C in Inland Central Western Brazil. J Med Virol. 2013 Mar;85(3):396-404. 2.85e-174 27
27PR
27RT
27
27PR
27RT
100 HIVDB
Alcantara (2013) Increasing heterosexual transmission of HIV-1 subtype C in Inland Central Western Brazil J. Med. Virol. 85 (3), 396-404 (2013) 4e-170 28
28PR
28RT
31
31PR
31RT
90 HIVDB
Aleman (2014) Performance of an in-house human immunodeficiency virus type 1 genotyping system for assessment of drug resistance in Cuba Unpublished 0  
14
14PR
14RT
0 Case report(s) / study subset
Alencar (2012) Prevalence of genotypes and primary drug resistance among HIV+ Brazilian blood donors Unpublished 0 300
300PR
300RT
327
327PR
327RT
91 HIVDB
Alexander (2002) INHIBITION of Human Immunodeficiency Virus Type 1 (HIV-1) Replication by a Two-Amino-Acid Insertion in HIV-1 Vif from a Nonprogressing Mother and Child J. Virol. 76 (20), 10533-10539 (2002) 0.027  
1
1IN
0 Gene fragment(s)
Alexiev (2015) Low HIV-1 transmitted drug resistance in Bulgaria against a background of high clade diversity J. Antimicrob. Chemother. (2015) In press 1.22e-149 221
221PR
219RT
221
221PR
221RT
100 HIVDB
Alexiev (2016) Origin and spread of HIV-1 in persons who inject drugs in Bulgaria Infect. Genet. Evol. (2016) In press 1.39e-149  
26
26PR
26RT
0 Pending
Ali (2010) Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones J. Med. Chem. 53 (21), 7699-7708 (2010) 0  
6
6PR
6RT
0 Laboratory/experimental isolate
Alizon (1986) GENETIC variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients Cell 46 (1), 63-74 (1986) 1e-165 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Allan (1993) SPECIES-SPECIFIC diversity among simian immunodeficiency viruses from African green monkeys J. Virol. 65 (6), 2816-2828 (1991) 2e-33  
8
8IN
0 Laboratory/experimental isolate
Allen (2005) SELECTIVE Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution J. Virol. 79 (21), 13239-13249 (2005) 0  
14
14PR
14RT
14IN
0 Evolution/quasispecies study
Allen (2008) Epidemiologically-Linked Transmission of HIV-1 Illustrates the Impact of Host Genetics on Virological Outcome Unpublished 2.23e-42  
23
23PR
23RT
0 Sequence quality
Altfeld (2003) HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus Nature 420 (6914), 434-439 (2002) 0  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Aman (2016) Optimization of full-length sequencing of HIV type 1 from Senegal Unpublished 0  
2
2PR
2RT
2IN
0 Unpublished
Amoedo (2011) Expression of APOBEC3G/3F and G-to-A Hypermutation Levels in HIV-1-Infected Children with Different Profiles of Disease Progression PLoS ONE 6 (8), E24118 (2011) 1e-60  
198
198PR
0 Evolution/quasispecies study
Amogne (2016) Phylogenetic Analysis of Ethiopian HIV-1 Subtype C Near Full-Length Genomes Reveals High Intrasubtype Diversity and a Strong Geographical Cluster AIDS Res. Hum. Retroviruses (2016) In press 0 133
133PR
133RT
24IN
151
151PR
151RT
24IN
88 HIVDB
An (2012) Reconstituting the epidemic history of CRF01_AE among MSM in Liaoning, northeastern China: Implication in expanding MSM epidemic in China J. Virol. (2012) In press 0 39
39PR
39RT
39IN
39
39PR
39RT
39IN
100 HIVDB
An (2016) A Novel HIV-1 Second-Generation Recombinant Form (CRF01_AE/CRF07_BC) among heterosexuals in Nei Monggoi Autonomous Region in China AIDS Res. Hum. Retroviruses (2016) In press 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Ana Planinic (2014) The prevalence and patterns of genotypic resistance to antiretroviral drugs in patients with virological failure from Croatia: 2008-2012 Thesis (2014) University Hospital for Infectous Di 3.01e-136  
101
101PR
101RT
0 Pending
Ana Planinic (2016) The prevalence and patterns of genotypic resistance to antiretroviral drugs in patients with virological failure from Croatia: 2008-2015 Unpublished 1.89e-135  
43
43PR
43RT
0 Unpublished
Anderson (2000) TESTING the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E J. Virol. 74 (22), 10752-10765 (2000) 1e-164 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
Anderson (1993) ANALYSIS of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques Virology 195 (2), 616-626 (1993) 5e-99  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Andersson (1999) MOLECULAR characterization of HIV-1 and HIV-2 in individuals from Guinea-Bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa Virology 261 (1999) In press 2e-66 7
7RT
7
7RT
100 HIVDB
Andreani (2008) CLINICAL evolution and antiretroviral resistance patterns in HIV-1 dual infected patients in Argentina Unpublished 0  
119
119PR
119RT
0 Evolution/quasispecies study
Andreotti (2009) Comparison of HIV type 1 sequences from plasma, cell-free breast milk, and cell-associated breast milk viral populations in treated and untreated women in Mozambique AIDS Res. Hum. Retroviruses 25 (7), 707-711 (2009) 5.72e-148  
296
147PR
149RT
0 Evolution/quasispecies study
Andresen (2007) CHARACTERIZATION of Near Full-Length Genomes of HIV Type 1 Strains in Denmark: Basis for a Universal Therapeutic Vaccine AIDS Res. Hum. Retroviruses 23 (11), 1442-1448 (2007) 0 17
17PR
17RT
17IN
17
17PR
17RT
17IN
100 HIVDB
Anta (2010) Identification of a new HIV-1 circulating recombinant form in Spain Unpublished 0  
4
4PR
4RT
0 Case report(s) / study subset
Anton (2004) GENOTYPIC Resistance to Efavirenz/Protease Inhibitor Regimens Unpublished 0  
219
219PR
219RT
0 ARV Rx and/or other data are N/A
Antoniadou (2013) Molecular Epidemiology of HIV Type 1 Infection in Northern Greece (2009-2010): Evidence of a Transmission Cluster of HIV Type 1 Subtype A1 Drug-Resistant Strains Among Men Who Have Sex with Men AIDS Res. Hum. Retroviruses (2013) In press 7e-64 91
91PR
91
91PR
100 HIVDB
Antoniadou (2014) Short Communication: Molecular Epidemiology of HIV Type 1 Infection in Northern Greece (2009-2010): Evidence of a Transmission Cluster of HIV Type 1 Subtype A1 Drug-Resistant Strains Among Men Who Have Sex with Men AIDS Res. Hum. Retroviruses 30 (3), 225-232 (2014) 8.79e-150 105
7PR
98RT
105
7PR
98RT
100 HIVDB
Apetrei (1998) HUMAN immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility J. Virol. 72 (5), 3534-3538 (1998) 1e-77 14
14RT
14
14RT
100 HIVDB
Apetrei (2003) HIV type 1 diversity in Northeastern Romania in 2000-2001 based on phylogenetic analysis of pol sequences from patients failing antiretroviral therapy AIDS Res. Hum. Retroviruses 19 (12), 1155-1161 (2003) 1e-117 163
77PR
86RT
163
77PR
86RT
100 HIVDB
Apetrei (2004) DIRECT Inoculation of Simian Immunodeficiency Virus from Sooty Mangabeys in Black Mangabeys (Lophocebus aterrimus): First Evidence of AIDS in a Heterologous African Species and Different Pathologic Outcomes of Experimental Infection J. Virol. 78 (21), 11506-11518 (2004) 4e-71  
18
18IN
0 Laboratory/experimental isolate
Apetrei (2005) MOLECULAR Epidemiology of Simian Immunodeficiency Virus SIVsm in U.S. Primate Centers Unravels the Origin of SIVmac and SIVstm J. Virol. 79 (14), 8991-9005 (2005) 4e-90 47
47IN
47
47IN
100 HIVDB
Apetrei (2006) POTENTIAL for HIV transmission through unsafe injections AIDS 20 (7), 1074-1076 (2006) 1e-148  
27
27PR
27RT
0 ARV Rx and/or other data are N/A
Apetrei (2007) SIVSMM Subtypes Induce Specific Immunologic and Virologic Changes in Naturally-Infected Sooty Mangabeys Unpublished 3e-70  
96
96IN
0 Evolution/quasispecies study
Arenas (2016) Influence of mutation and recombination on HIV-1 in vitro fitness recovery Mol. Phylogenet. Evol. 94 (PT A), 264-270 (2016) 0  
12
12PR
12RT
12IN
0 Laboratory/experimental isolate
Arien (2005) REPLICATIVE fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time AIDS 19 (15), 1555-1564 (2005) 0 23
23PR
23RT
23
23PR
23RT
100 HIVDB
Arien (2016) Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398 J. Antimicrob. Chemother. (2016) In press 0  
4
4PR
4RT
0 Case report(s) / study subset
Arien (2016) The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates J. Virol. 79 (14), 8979-8990 (2005) 5.41e-103  
15
15RT
0 Gene fragment(s)
Armenia (2011) Study of Genotypic and Phenotypic HIV-1 Dynamics of Integrase Mutations During Raltegravir Treatment: A Refined Analysis by Ultra-Deep 454 Pyrosequencing J Infect Dis (2012) 1e-168 40
40IN
40
40IN
100 HIVDB
Arnold (1995) AT least five HIV-1 sequence subtypes (A, B, C, D, A/E) occur in England AIDS Res. Hum. Retroviruses 11 (3), 427-429 (1995) 1e-126  
4
4PR
0 Case report(s) / study subset
Arora (2016) Genotyping protease-inhibitor-related mutations in an HIV-1 isolate from a treatment-naive patient in Chandigarh, India Unpublished 1.31e-46  
1
1PR
1RT
0 Case report(s) / study subset
Arroyo (2004) HIV Type 1 Subtypes among Blood Donors in the Mbeya Region of Southwest Tanzania AIDS Res. Hum. Retroviruses 20 (8), 895-901 (2004) 0 20
20PR
20RT
20IN
20
20PR
20RT
20IN
100 HIVDB
Arroyo (2006) HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania AIDS 19 (14), 1517-1524 (2005) 0 14
14PR
14RT
14IN
14
14PR
14RT
14IN
100 HIVDB
Arruda (2012) Short communication: intermediate prevalence of HIV type 1 primary antiretroviral resistance in Ceara State, Northeast Brazil AIDS Res. Hum. Retroviruses 27 (2), 153-156 (2011) 1.68e-151 148
74PR
74RT
148
74PR
74RT
100 HIVDB
Arruda (2009) Genetic diversity on the integrase region of the pol gene among HIV-1-infected patients naive for integrase inhibitors in Sao Paulo city, Brazil AIDS Res. Hum. Retroviruses 26, 1 (2010) 1e-168 76
76IN
76
76IN
100 HIVDB
Arruda (2010) Differences in frequencies of pi-resistance mutations from HIV-1 of different subtypes (B, C and F) in a cohort of patients failing arv therapy Unpublished 0 911
911PR
911RT
911
911PR
911RT
100 HIVDB
Arruda (2016) Brazilian network for HIV Drug Resistance Surveillance (HIV-BresNet): a large survey of naive-treatment individuals Unpublished 5.55e-168  
1566
1566PR
1566RT
0 Unpublished
Atkinson (2000) CORRELATION between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine J. Infect. Dis. 182 (2), 420-427 (2000) 1e-123 49
49PR
78
50PR
28RT
62 HIVDB
Aulicino (2004) CIRCULATION of novel HIV type 1 A, B/C, and F subtypes in Argentina AIDS Res. Hum. Retroviruses 21 (2), 158-164 (2005) 0 1
1PR
1RT
1IN
3
3PR
3RT
1IN
33 HIVDB
Aulicino (2005) SEQUENCE Analysis of a South American HIV Type 1 BC Recombinant AIDS Res. Hum. Retroviruses 21 (10), 894-896 (2005) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Aulicino (2009) HIV-1 non-nucleoside resistance mutations K103N + L100I are strongly associated with nucleoside resistance mutation L74V in BF recombinants from Argentine children under treatment failure, and reduce susceptibility to Etravirine Antivir Ther. 2010;15(4):641-50 2.73e-160 8
8PR
8RT
8
8PR
8RT
100 HIVDB
Aulicino (2010) HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations Antivir. Ther. (Lond.) 15 (4), 641-650 (2010) 6.27e-159 63
63PR
63RT
63
63PR
63RT
100 HIVDB
Aulicino (2013) Longitudinal analysis of HIV-1 BF1 recombinant strains in vertically infected children from Argentina reveals a decrease in CRF12_BF pol gene mosaic patterns and high diversity of BF unique recombinant forms Infect. Genet. Evol. 11 (2), 349-357 (2011) 6.74e-162 123
123PR
123RT
123
123PR
123RT
100 HIVDB
Aulicino (2015) Drug resistance in HIV infected children from Argentina Unpublished 2.59e-154  
23
23PR
23RT
0 Case report(s) / study subset
Auswinporn (2001) GENOTYPIC subtyping of the HIV-1 polymerase gene in 30 naave patients from Thailand Southeast Asian J. Trop. Med. Public Health 32 (2), 346-350 1e-121 27
27PR
27RT
27
27PR
27RT
100 HIVDB
Auwanit (2001) FULL-LENGTH sequences of two CRF01_ae (subtype e) HIV type 1 isolates from 1995 samples of patients with sexually transmitted diseases in Thailand AIDS Res. Hum. Retroviruses 17 (9), 867-871 (2001) 1e-165  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Auwanit (2009) Detection of drug resistance-associated and background mutations in human immunodeficiency virus type 1 CRF01_AE protease and reverse transcriptase derived from drug treatment-naive patients residing in central Thailand AIDS Res. Hum. Retroviruses 25 (6), 625-631 (2009) 4e-173 109
59PR
50RT
189
139PR
50RT
57 HIVDB
Avanzi (2016) Direct Submission Submitted (08-MAR-2016) Virology Laboratory, Unive 0  
32
32PR
32RT
0 Case report(s) / study subset
Avi (2009) Emerging transmitted drug resistance in treatment-naive human immunodeficiency virus-1 CRF06_cpx-infected patients in Estonia. Scand J Infect Dis 1e-144 55
55PR
55RT
55
55PR
55RT
100 HIVDB
Avi (2009) Characterization of integrase region polymorphisms in HIV type 1 CRF06_cpx viruses in treatment-naive patients in Estonia. ARHR 1e-164 112
112IN
114
114IN
98 HIVDB
Avi (2009) Prevalence of Drug Resistance Mutations of Human Immunodeficiency Virus - 1 CRF06_cpx in Treatment-Naive Patients in Estonia in 2008 Unpublished 4e-172 90
90PR
90RT
90
90PR
90RT
100 HIVDB
Avi (2015) Near Full-Length Genome Sequences of HIV-1 CRF06/A1 recombinat forms in Estonian Intravenous Drug Users Population Unpublished 0  
10
10PR
10RT
10IN
0 Unpublished
Avi (2009) Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia J. Med. Virol. 81 (6), 953-958 (2009) 9.16e-161 142
86PR
56RT
143
87PR
56RT
99 HIVDB
Avi (2014) Transmitted Drug Resistance Is Still Low in Newly Diagnosed Human Immunodeficiency Virus Type 1 CRF06_cpx-Infected Patients in Estonia in 2010 AIDS Res. Hum. Retroviruses 30 (3), 278-283 (2014) 1.19e-169 227
227PR
227RT
227
227PR
227RT
100 HIVDB
Avi (2014) Failure of ddI Containing HAART is Associated with the Selection of L74V and L74I Mutations in HIV-1 CRF06_cpx Infected Patients in Estonia Unpublished 1.28e-161  
45
45PR
45RT
0 Case report(s) / study subset
Avi (2012) Transmitted drug resistance is still low in newly diagnosed human immunodeficiency virus type 1 CRF06_cpx-infected patients in Estonia in 2010. AIDS Res Hum Retroviruses. 2014 Mar;30(3):278-83. 1e-169 17
17PR
17RT
17
17PR
17RT
100 HIVDB
Avidor (2013) Transmission Patterns of HIV-Subtypes A/AE versus B: Inferring Risk-Behavior Trends and Treatment-Efficacy Limitations from Viral Genotypic Data Obtained Prior to and during Antiretroviral Therapy PLoS ONE 8 (3), E57789 (2013) 5.23e-146 232
232PR
232RT
236
236PR
236RT
98 HIVDB
Avila-Rios (2013) National Prevalence and Trends of HIV Transmitted Drug Resistance in Mexico PLoS ONE 6 (11), E27812 (2011) 0 1648
1648PR
1639RT
1648
1648PR
1639RT
100 HIVDB
Ay (2016) Transmitted Drug Resistance in Newly Diagnosed, Treatment-Naive, HIV Type 1- Infected Patients in Hungary Unpublished 0  
120
60PR
60RT
0 Unpublished
AYEHUMIE (1991) Human immunodeficiency virus type 1 proviral DNA Unpublished (1991) 4e-41  
8
8PR
0 Gene fragment(s)
Ayouba (2009) Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Cote d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study AIDS Res. Hum. Retroviruses 25 (11), 1193-1196 (20 2e-171 534
267PR
267RT
534
267PR
267RT
100 HIVDB
Ayouba (2013) Evidence for continuing cross-species transmission of SIVsmm to humans: characterization of a new HIV-2 lineage in rural Cote d'Ivoire AIDS 27 (15), 2488-2491 (2013) 0 1
1PR
1RT
1IN
3
2PR
2RT
2IN
33 HIVDB
Ayouba (2015) Molecular characterization of a new mosaic Simian Immunodeficiency Virus in a naturally infected tantalus monkey (Chlorocebus tantalus) from Cameroon: a challenge to the virus-host co-evolution of SIVagm in African green monkeys Infect. Genet. Evol. 30, 65-73 (2015) 0  
1
1PR
1RT
1IN
0 NHPL/SIV
Azam (2012) Emergence of drug resistance-associated mutations in HIV-1 subtype C protease gene in north India. Virus Genes. 2013 Dec;47(3):422-8. 1e-60  
51
51PR
0 Case report(s) / study subset
Azam (2013) Prevalence of primary drug resistance-associated mutations to protease inhibitors in HIV-1 infected patients Unpublished 4e-61  
51
51PR
0 ARV Rx and/or other data are N/A
Azam (2013) Emergence of drug resistance-associated mutations in HIV-1 subtype C protease gene in north India Virus Genes 47 (3), 422-428 (2013) 9.22e-52  
2
2PR
0 Case report(s) / study subset
Azam (2014) Trends of drug-resistance-associated mutations in the reverse transcriptase gene of HIV type 1 isolates from North India Arch. Virol. 159 (4), 719-725 (2014) 7.23e-149 103
103RT
103
103RT
100 HIVDB
Azevedo-Pereira (1998) Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo. J Virol. 2e-97  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Baalwa (2012) Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones Virology 436 (1), 33-48 (2013) 0  
500
216PR
216RT
500IN
0 Evolution/quasispecies study
Babic (2005) PREVALENCE of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naive patients in Slovenia, 2000-2004 Virus Res. 118 (1-2), 156-163 (2006) 0 76
76PR
76RT
77
77PR
77RT
98 HIVDB
Babic (2005) MOLECULAR epidemiology of HIV-1 subtypes based on analysis of pol sequences in Slovenia, 1996-2005 J. Med. Virol. 78 (8), 997-1002 (2006) 0  
7
7PR
7RT
0 Case report(s) / study subset
Bacheler (2000) HUMAN immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy Antimicrob. Agents Chemother. 44 (9), 2475-2484 (2000) 1e-130 3669
3646PR
3662RT
3708
3708PR
3708RT
98 HIVDB
Bacheler (2001) GENOTYPIC correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy J. Virol. 75 (11), 4999-5008 (2001) 1e-126 67
66PR
67RT
87
84PR
87RT
77 HIVDB
Badreddine (2007) IDENTIFICATION and Characterization of HIV Type 1 Subtypes Present in the Kingdom of Saudi Arabia: High Level of Genetic Diversity Found AIDS Res. Hum. Retroviruses 23 (5), 667-674 (2007) 0 60
6PR
6RT
60IN
60
6PR
9RT
60IN
100 HIVDB
Baesi (2013) Antiretroviral drug resistance and new subtypes in HIV-infected patients in Tehran, Iran Unpublished 2.32e-162  
84
84RT
0 ARV Rx and/or other data are N/A
Baeten (2014) Risk factors associated with HIV acquisition from outside of identified sexual partnership Unpublished 2.08e-162 296
286PR
294RT
296
287PR
296RT
100 HIVDB
Baeten (2011) Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons J. Infect. Dis. 203 (1), 117-121 (2011) 1.19e-169  
65
65RT
0 Case report(s) / study subset
Baeten (2013) Antiretroviral prophylaxis for HIV prevention in heterosexual men and women N. Engl. J. Med. 367 (5), 399-410 (2012) 0  
176
176PR
176RT
0 Case report(s) / study subset
Bahls (2014) Prevalence of transmitted drug resistance in recently and chronically infected individuals from northwestern and northern Parana Unpublished 8.13e-171  
163
160PR
162RT
0 Unpublished
Baier (1990) COMPLETE nucleotide sequence of a simian immunodeficiency virus from African green monkeys: a novel type of intragroup divergence Virology 176 (1), 216-221 (1990) 1e-109 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Bailey (2016) Arteriviruses, pegiviruses, and lentiviruses are common among wild African monkeys J. Virol. (2016) In press 0  
33
33PR
33RT
33IN
0 NHPL/SIV
Bailey (2007) EVOLUTION of HIV-1 in an HLA-B*57-Positive Patient during Virologic Escape J. Infect. Dis. 196 (1), 50-55 (2007) 0  
43
37PR
38RT
6IN
0 Evolution/quasispecies study
Bailey (2008) TRANSMISSION of Human Immunodeficiency Virus Type 1 from a Patient Who Developed AIDS to an Elite Suppressor J. Virol. 82 (15), 7395-7410 (2008) 0  
14
7PR
7RT
14IN
0 Case report(s) / study subset
Bailey (2016) Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells J. Virol. 80 (13), 6441-6457 (2006) 6.42e-129  
1604
1604RT
0 Evolution/quasispecies study
Baker (2007) HIV subtypes distribution and implication for antiretroviral treatment in a Ugandan population. J Int Assoc Physicians AIDS Care (Chic) 0 46
45PR
46RT
46
45PR
46RT
100 HIVDB
Balakrishnan (2005) HIV Type 1 Genotypic Variation in an Antiretroviral Treatment-Naive Population in Southern India AIDS Res. Hum. Retroviruses 21 (4), 301-305 (2005) 1e-139 50
50PR
50RT
50
50PR
50RT
100 HIVDB
Balamane (2012) Panel of Prototypical Recombinant Infectious Molecular Clones Resistant to Nevirapine, Efavirenz, Etravirine, and Rilpivirine Antimicrob. Agents Chemother. (2012) In press 1e-176 10
10RT
10
10RT
100 HIVDB
Balamurugan (2016) Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination J. Virol. 82 (6), 2784-2791 (2008) 6.82e-105  
28
28PR
28RT
0 Gene fragment(s)
Baldanti (2010) Early emergence of raltegravir resistance mutations in patients receiving HAART salvage regimens J. Med. Virol. 82 (1), 116-122 (2010) 1e-156 11
11IN
11
11IN
100 HIVDB
Baldrich-Rubio (2001) A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa J. Gen. Virol. 82 (PT 5), 1095-1106 (2001) 1e-161 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Balode (2010) Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia J. Med. Virol. 82 (12), 2013-2018 (2010) 0 117
117PR
117RT
124
124PR
124RT
94 HIVDB
Balotta (2000) Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1 infected Italian patients with virologic failure. JAIDS 1e-133 149
132PR
149RT
157
137PR
157RT
94 HIVDB
Balotta (2000) PREVALENCE of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals Antivir. Ther. (Lond.) 5 (1), 7-14 (2000) 1e-128 71
33PR
38RT
71
33PR
38RT
100 HIVDB
Balotta (2001) INCREASING prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences J. Acquir. Immune Defic. Syndr. 27 (5), 499-505 (2001) 1e-100 19
19PR
19RT
19
19PR
19RT
100 HIVDB
Bang (2007) PREVALENCE of primary antiretroviral resistance: trends in Korea AIDS Res. Hum. Retroviruses 24 (1), 83-85 (2008) 0 81
81PR
81RT
81
81PR
81RT
100 HIVDB
Banke (2009) Positive selection pressure introduces secondary mutations at Gag cleavage sites in human immunodeficiency virus type 1 harboring major protease resistance mutations J. Virol. 83 (17), 8916-8924 (2009) 4e-60 364
364PR
364
364PR
100 HIVDB
Bansode (2011) Drug Resistance Mutations in Drug-Naive HIV Type 1 Subtype C-Infected Individuals from Rural Malawi AIDS Res. Hum. Retroviruses 27 (4), 439-444 (2011) 5.07e-164  
432
232PR
200RT
0 ARV Rx and/or other data are N/A
Bao (2008) MOLECULAR tracing of sexual HIV Type 1 transmission in the southwest border of China AIDS Res. Hum. Retroviruses 24 (5), 733-742 (2008) 0 2
2PR
2RT
2
2PR
2RT
100 HIVDB
Bao (2008) Molecular tracing of sexual HIV Type 1 transmission in the southwest border of China AIDS Res. Hum. Retroviruses 24 (5), 733-742 (2008) 0 42
42PR
42RT
42
42PR
42RT
100 HIVDB
Bao (2014) Characteristics of HIV-1 Natural Drug Resistance-Associated Mutations in Former Paid Blood Donors in Henan Province, China PLoS ONE 9 (2), E89291 (2014) 0 107
99PR
107RT
107
107PR
107RT
100 HIVDB
Bar (2010) Wide variation in the multiplicity of HIV-1 infection among injection drug users J. Virol. 84 (12), 6241-6247 (2010) 3e-16  
390
390IN
0 Evolution/quasispecies study
Bar-Magen (2009) Comparative Biochemical Analysis of HIV-1 Subtype B and C Integrase Enzymes AIDS. 2010 Sep 10;24(14):2171-9. 1e-165  
2
2IN
0 Laboratory/experimental isolate
Barber (2012) Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor J. Antimicrob. Chemother. (2012) In press 0 31
31PR
31RT
31
31PR
31RT
100 HIVDB
Barbian (2015) Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas MBio 6 (2), e00296-15 (2015) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Barditch-Crovo (2001) PHASE i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults Antimicrob. Agents Chemother. 45 (10), 2733-2739 (2001) 4e-96 14
14RT
14
14RT
100 HIVDB
Barlow (2001) RECOMBINANT strains of HIV type 1 in the United Kingdom AIDS Res. Hum. Retroviruses 17 (5), 467-474 (2001) 1e-109  
12
12PR
9RT
0 ARV Rx and/or other data are N/A
Barlow (2003) CHARACTERIZATION of a novel simian immunodeficiency virus (SIVmonNG1) genome sequence from a mona monkey (Cercopithecus mona) J. Virol. 77 (12), 6879-6888 (2003) 3e-92 2
1PR
1RT
2IN
2
1PR
1RT
2IN
100 HIVDB
Barnett (1993) DISTINGUISHING features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain J. Virol. 67 (2), 1006-1014 (1993) 0  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Barnett (1996) DIRECT Submission Submitted (11-OCT-1995) Barton Bryant, HIV Database, Los Ala 2e-98  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Barral (2014) Analysis of HIV-1 drug resistance mutations in the reverse transcriptase C-terminal portions and co-occurrence with polymerase domain mutations in different subtypes from patients under virological failure in southern Brazil Unpublished 0  
47
7PR
47RT
0 Pending
Barreto (2006) Trends in antiretroviral drug resistance and clade distributions among HIV-1--infected blood donors in Sao Paulo, Brazil. JAIDS 1e-142 6
6PR
6RT
6
6PR
6RT
100 HIVDB
Barreto (2016) Trends in antiretroviral drug resistance and clade distributions among HIV-1--infected blood donors in Sao Paulo, Brazil J. Acquir. Immune Defic. Syndr. 41 (3), 338-341 (2 1.01e-146 335
335PR
335RT
335
335PR
335RT
100 HIVDB
Barrie (1996) NATURAL variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1 Virology 219 (2), 407-416 (1996) 1e-126  
37
37PR
0 Case report(s) / study subset
Bartolo (2007) HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique. JAIDS 0 113
37PR
77RT
113
48PR
111RT
100 HIVDB
Bartolo (2007) Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected individuals in Angola: evidence for low level of transmitted drug resistance. AAC 1e-170 139
19PR
120RT
140
19PR
140RT
99 HIVDB
Bartolo (2010) Origin and epidemiological history of HIV-1 CRF14_BG. PLoS One 0 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Bartolo (2008) Analysis of HIV-1 protease and retrotranscriptase in drug-naive patients from Mozambique Unpublished 4.02e-152 75
74PR
1RT
76
76PR
73RT
98 HIVDB
Bartolo (2009) Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic Infect. Genet. Evol. 9 (4), 672-682 (2009) 6e-169 123
122PR
1RT
124
122PR
119RT
99 HIVDB
Bartolo (2014) HIV-1 diversity, transmission dynamics and primary drug resistance in Angola. PLoS One. 2014 Dec 5;9(12):e113626. 0 280
140PR
140RT
281
141PR
140RT
99 HIVDB
Bartolo (2016) Sequencing and phylogenetic analysis of near full-length HIV-1 subtypes H and J from Cabinda, Angola Unpublished 0 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Baryshev (2011) Genetic characterisation of HIV-1 strains recombinant form AG circulating in Siberia, Russia Zh Mikrobiol Epidemiol Immunobiol 0 14
14PR
14RT
14IN
17
17PR
17RT
17IN
82 HIVDB
Baudi (2016) Molecular epidemiology of co-infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe J. Med. Virol. (2016) In press 5.55e-168 164
164PR
164RT
164
164PR
164RT
100 HIVDB
Baxter (2006) GENOTYPIC changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir J. Virol. 80 (21), 10794-10801 (2006) 0 4996
3195PR
3195RT
4999
3198PR
3198RT
99 HIVDB
Beck (2007) OPTIMIZATION of the Oligonucleotide Ligation Assay (OLA), a Rapid and Inexpensive Test for Detection of HIV-1 Drug-Resistance Mutations, for Non-B Subtypes Unpublished 1.02e-153  
79
50PR
36RT
0 Case report(s) / study subset
Becker (1995) MOLECULAR and phylogenetic characterisation of a Guinea-Bissau-derived human immunodeficiency virus type 2 isolate Unpublished 1e-100  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Becker-Pergola (2000) ANALYSIS of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults AIDS Res. Hum. Retroviruses 16 (8), 807-813 (2000) 1e-115 54
27PR
27RT
54
27PR
27RT
100 HIVDB
Beer (1999) SIMIAN immunodeficiency virus (SIV) from sun-tailed monkeys (Cercopithecus solatus): evidence for host-dependent evolution of SIV within the C. lhoesti superspecies J. Virol. 73 (9), 7734-7744 (1999) 4e-97 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Beer (2000) PATTERNS of genomic sequence diversity among their simian immunodeficiency viruses suggest that L'Hoest monkeys (Cercopithecus lhoesti) are a natural lentivirus reservoir J. Virol. 74 (8), 3892-3898 (2000) 3e-99 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Beer (2001) CHARACTERIZATION of novel simian immunodeficiency viruses from red-capped mangabeys from Nigeria (SIVrcmNG409 and -NG411) J. Virol. 75 (24), 12014-12027 (2001) 1e-133 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Beerenwinkel (2002) DIVERSITY and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype Proc. Natl. Acad. Sci. U.S.A. 99 (12), 8271-8276 (2002) 1e-126  
489
466PR
467RT
0 Sequence Quality
Belec (2014) Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays. Niger Med J. 2015 Nov-Dec;56(6):420-4. 0 37
37PR
37RT
38
38PR
38RT
97 HIVDB
Belec (2013) HIV drug resistance mutations in HIV1 variants from adults living in Gabon Unpublished 8.87e-142  
30
27PR
28RT
0 ARV Rx and/or other data are N/A
Bellocchi (2009) Subtype Analysis and Mutations to Antiviral Drugs in HIV-1-Infected Patients From Mozambique Before Initiation of Antiretroviral Therapy: Results From the DREAM Programme J Med Virol (2005) 1e-177 59
59PR
59RT
59
59PR
59RT
100 HIVDB
Beloukas (2016) Assessment of phylogenetic sensitivity for reconstructing HIV-1 epidemiological relationships Unpublished 4.84e-147  
9
5PR
4RT
0 Case report(s) / study subset
Belyhun (2015) Long term antiretroviral therapy is responsible for high rate of HBV polymerase and HBs antigen escape mutations during HIV-1 co-infection in Ethiopia Unpublished 0  
8
8PR
8RT
0 Case report(s) / study subset
Benn (1993) Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire Science 1e-166  
1
1PR
1RT
1IN
0 Case report(s) / study subset
BENVENISTE (1988) Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2. J Virol. 1988 Jun;62(6):2091-101. 6e-99  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Berg (2016) A PAN-HIV STRATEGY FOR COMPLETE GENOME SEQUENCING J. Clin. Microbiol. (2015) In press 0  
56
56PR
56RT
56IN
0 NGS
Bermudez-Aza (2011) Antiretroviral resistance in MSM in Brazil Unpublished 0  
162
162PR
162RT
0 Pending
Bernardin (2003) PRIMARY Infection of a Male Plasma Donor with Divergent HIV Variants from the Same Source Followed by Rapid Fluctuations in Their Relative Frequency and Viral Recombination AIDS Res. Hum. Retroviruses 19 (11), 1009-1015 (2003) 0  
3
3PR
3RT
3IN
0 Case report(s) / study subset
Bernardin (2004) HUMAN immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes J. Virol. 79 (17), 11523-11528 (2005) 0 18
18PR
18RT
18IN
18
18PR
18RT
18IN
100 HIVDB
Bernardin (2006) DIRECT Submission Submitted (12-DEC-2005) Molecular Virology, Blood Systems Re 0  
13
13PR
13RT
13IN
0 Case report(s) / study subset
Bertine (2015) High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients Unpublished 1.5e-146 81
38PR
43RT
86
43PR
43RT
94 HIVDB
Bessong (2004) CHARACTERIZATION of Human Immunodeficiency Virus Type 1 from a Previously Unexplored Region of South Africa with a High HIV Prevalence AIDS Res. Hum. Retroviruses 21 (1), 103-109 (2005) 1e-168 26
13PR
13RT
26
13PR
13RT
100 HIVDB
Bessong (2005) RESISTANCE mutational analysis of HIV type 1 subtype C among rural South African drug-naive patients prior to large-scale availability of antiretrovirals AIDS Res. Hum. Retroviruses 22 (12), 1306-1312 (2006) 1e-177 75
40PR
35RT
75
40PR
35RT
100 HIVDB
Bessong (2010) Analysis of pol integrase gene sequences of HIV-1 infected treatment naive individuals in the Limpopo province of South Africa Unpublished 1e-164 88
88IN
89
89IN
98 HIVDB
Betancor (2012) Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy Retrovirology 9 (1), 68 (2012) 0 216
216PR
216RT
216
216PR
216RT
100 HIVDB
Bhalla (2009) Antiretroviral resistance-associated mutations and genomic diversity in reverse transcriptase and protease gene among drug-naive patients Unpublished 2.82e-161  
18
18PR
18RT
0 Case report(s) / study subset
Bhattacharya (2007) Founder effects in the assessment of HIV polymorphisms and HLA allele associations Science 315 (5818), 1583-1586 (2007) 2e-59  
28
28PR
0 Case report(s) / study subset
Bhusal (2013) HIV type 1 subtypes based on the pol gene and drug resistance mutations among Nepalese patients from central region of Nepal Unpublished 0  
20
20PR
20RT
0 ARV Rx and/or other data are N/A
Bhusal (2014) Genetic characterization of HIV-1 strains among different risk group of Nepalese patient from central region of Nepal Unpublished 0  
17
17PR
17RT
0 Unpublished
Bhusal (2016) Molecular epidemiology of HIV in central region of Nepal Unpublished 0  
10
10PR
10RT
10IN
0 Unpublished
Bhusal (2017) Prevalence of HIV-1 Subtypes and Antiretroviral Drug Resistance Mutations in Nepal Curr. HIV Res. 14 (6), 517-524 (2016) 0  
10
10PR
10RT
0 Pending
Bibollet-Ruche (1996) GENETIC diversity of simian immunodeficiency viruses from West African green monkeys: evidence of multiple genotypes within populations from the same geographical locale J. Virol. 71 (1), 307-313 (1997) 1e-30  
10
10IN
0 Gene fragment(s)
Bibollet-Ruche (2004) NEW simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade J. Virol. 78 (14), 7748-7762 (2004) 0 4
4PR
4RT
4IN
11
4PR
6RT
11IN
36 HIVDB
Bibollet-Ruche (2005) COMPLETE genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2) AIDS Res. Hum. Retroviruses 20 (12), 1377-1381 (2004) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Bibollet-Ruche (2005) GENETIC characterization of accessory genes from human immunodeficiency viruses type 1 group O Unpublished 0.00000003  
14
14IN
0 Gene fragment(s)
Bibollet-Ruche (2012) Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptation J. Clin. Invest. 122 (5), 1644-1652 (2012) 0  
3
3PR
3RT
3IN
0 Laboratory/experimental isolate
Bibollet-Ruche (2017) New simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade J. Virol. 78 (14), 7748-7762 (2004) 0  
1
1PR
1RT
1IN
0 NHPL/SIV
Biesinger (2007) CHANGES in simian immunodeficiency virus reverse transcriptase alleles that appear during infection of macaques enhance infectivity and replication in CD4(+) T cells Virology 370 (1), 184-193 (2008) 0  
8
8RT
0 Case report(s) / study subset
Bila (2012) Evolution of primary HIV drug resistance in a subtype C dominated epidemic in Mozambique Unpublished 0 265
265PR
253RT
1IN
377
377PR
366RT
1IN
70 HIVDB
Billings (2015) The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006 PLoS ONE 10 (8), E0135124 (2015) 0 58
58PR
58RT
58IN
58
58PR
58RT
58IN
100 HIVDB
Billings (2017) HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania AIDS Res. Hum. Retroviruses (2016) In press 0 97
95PR
95RT
97IN
98
95PR
95RT
98IN
98 HIVDB
Billong (2013) Population-Based Monitoring of Emerging HIV-1 Drug Resistance on Antiretroviral Therapy and Associated Factors in a Sentinel Site in Cameroon: Low Levels of Resistance but Poor Programmatic Performance PLoS ONE 8 (8), E72680 (2013) 0 146
146PR
146RT
146
146PR
146RT
100 HIVDB
Binverted question markelec (2000) HIGH levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure of protease inhibitor-containing antiretroviral combination therapy J. Infect. Dis. 181 (5), 1808-1812 (2000) 1e-128 100
100PR
100
100PR
100 HIVDB
Blanco (2015) Near full length HIV-1 subtype B from Cuban individuals Unpublished 0  
4
4PR
4RT
4IN
0 Case report(s) / study subset
Blankson (2007) ISOLATION and Characterization of Replication-Competent HIV-1 from a Subset of Elite Suppressors J. Virol. 81 (5), 2508-2518 (2007) 0  
6
6PR
6RT
6IN
0 Case report(s) / study subset
Blankson (2009) HIV-1 Evolution Following Transmission to an HLA-B*5801 Positive Subject J Infect Dis. 2009 Dec 15;200(12):1820-4. 0  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Bleiber (2001) INDIVIDUAL contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1 J. Virol. 75 (7), 3291-3300 (2001) 1e-112  
21
15PR
15RT
0 Case report(s) / study subset
Blick (2006) THE Probable Source of Both the Primary Multidrug-Resistant (MDR) HIV-1 Strain Found in a Patient with Rapid Progression to AIDS and a Second Recombinant MDR Strain Found in a Chronically HIV-1-Infected Patient J. Infect. Dis. 195 (9), 1250-1259 (2007) 1e-163  
13
13PR
13RT
0 Case report(s) / study subset
Bodelle (2004) IDENTIFICATION and Genomic Sequence of an HIV Type 1 Group N Isolate from Cameroon AIDS Res. Hum. Retroviruses 20 (8), 902-908 (2004) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Boeri (2003) EVOLUTIONARY characteristics of HIV-1 variants resistant to protease inhibitors in the absence of drug-selective pressure AIDS Res. Hum. Retroviruses (2003) In press 0  
18
18PR
18RT
0 Case report(s) / study subset
Boerma (2016) High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children J Int AIDS Soc 19 (1), 21140 (2016) 4.75e-166  
90
90PR
90RT
0 Pending
Bogh (2001) INVESTIGATING association between baseline HIV-1 genotypic resistance and virological response among protease in-hibitor-naive patients treated with HAART Unpublished 1e-133  
180
112PR
68RT
0 ARV Rx and/or other data are N/A
Boillot (2015) Programmatic feasibility of dried blood spots for the virological follow-up of patients on antiretroviral treatment in Nord Kivu, Democratic Republic of the Congo J. Acquir. Immune Defic. Syndr. (2015) In press 0 55
42PR
55RT
55
42PR
55RT
100 HIVDB
Bolcic (2012) A clustering phenomenon among HCV-1a strains among patients coinfected with HIV from Buenos Aires, Argentina J. Med. Virol. 84 (4), 570-581 (2012) 1e-179  
4
4PR
4RT
0 Case report(s) / study subset
Bolcic (2011) A clustering phenomenon among HCV-1a strains among patients coinfected with HIV from Buenos Aires, Argentina. J Med Virol. 2012 Apr;84(4):570-81. 0  
4
4PR
4RT
0 Case report(s) / study subset
Bolivar (2009) The Challenge of HIV-1 Genetic Diversity: Discordant CD4+ T-Cell Count and Viral Load in an Untreated Patient Infected With a Subtype F Strain J. Acquir. Immune Defic. Syndr. 52 (5), 659-661 (2 1e-161  
1
1IN
0 Case report(s) / study subset
Bond (2015) Natural history of epidemic and non-epidemic HIV-2 groups Unpublished 0  
1
1PR
1RT
1IN
0 Unpublished
Bonhoeffer (2008) Evidence for positive epistasis in HIV-1 Science 306 (5701), 1547-1550 (2004) 0 9467
9467PR
9467RT
9467
9467PR
9467RT
100 HIVDB
Bonney (2014) Antiretroviral resistance mutation profiles of patients on second-line therapy in Accra, Ghana Unpublished 0  
40
40PR
29RT
0 Unpublished
Bontell (2011) Transmitted drug resistance and phylogenetic analysis of HIV CRF01_AE in Northern Vietnam Infect. Genet. Evol. 12 (2), 448-452 (2012) 7.51e-161 63
63PR
63RT
63
63PR
63RT
100 HIVDB
Bonura (2010) Transmission of drug-resistant HIV type 1 strains in HAART-naive patients: a 5-year retrospective study in Sicily, Italy. ARHR 0 109
109PR
109RT
109
109PR
109RT
100 HIVDB
Bouchard (2004) HIV Type 1 Drug Resistance among Naive Patients from Venezuela AIDS Res. Hum. Retroviruses 23 (3), 482-485 (2007) 1e-140 37
17PR
20RT
37
17PR
21RT
100 HIVDB
Bouchonnet (2012) Quantification of the effects on viral DNA synthesis of reverse transcriptase mutations conferring human immunodeficiency virus type 1 resistance to nucleoside analogues J. Virol. 79 (2), 812-822 (2005) 0  
1
1RT
0 Laboratory/experimental isolate
Boue (2015) High Rate of Simian Immunodeficiency Virus (SIV) Infections in Wild Chimpanzees in Northeastern Gabon Viruses 7 (9), 4997-5015 (2015) 7e-93  
56
56IN
0 Gene fragment(s)
Bourara (2007) TARGET cell APOBEC3C can induce limited G-to-A mutation in HIV-1 PLoS Pathog. 3 (10), 1477-1485 (2007) 4e-52  
2
2PR
0 Case report(s) / study subset
Bouzeghoub (2005) HIGH Diversity of HIV Type 1 in Algeria AIDS Res. Hum. Retroviruses 22 (4), 367-372 (2006) 1e-149 252
135PR
117RT
252
135PR
117RT
100 HIVDB
Bouzeghoub (2008) FIRST Observation of HIV Type 1 Drug Resistance Mutations in Algeria AIDS Res. Hum. Retroviruses 24 (11), 1467-1473 (2008) 2e-173 117
62PR
55RT
117
62PR
55RT
100 HIVDB
Bracho (2016) Emerging trends in CRF02_AG variants transmission among men who have sex with men in Spain J. Acquir. Immune Defic. Syndr. 65 (3), E130-E133 0 41
41PR
41RT
41
41PR
41RT
100 HIVDB
Brachtel (2002) DEMONSTRATION of de Novo HIV Type 1 Production by Detection of Multiply Spliced and Unspliced HIV Type 1 RNA in Paraffin-Embedded Tonsils AIDS Res. Hum. Retroviruses 18 (11), 785-790 (2002) 1e-62  
43
43PR
0 Case report(s) / study subset
Bradshaw (2007) NOVEL Drug Resistance Pattern Associated with the Mutations K70G and M184V in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Antimicrob. Agents Chemother. 51 (12), 4489-4491 (2007) 0 13
4PR
13RT
13
4PR
13RT
100 HIVDB
Brandin (2003) POL Gene Sequence Variation in Swedish HIV-2 Patients Failing Antiretroviral Therapy AIDS Res. Hum. Retroviruses 19 (7), 543-550 (2003) 3e-97 30
30PR
30RT
30
30PR
30RT
100 HIVDB
Brann (2006) FUNCTIONAL Correlation between a Novel Amino Acid Insertion at Codon 19 in the Protease of Human Immunodeficiency Virus Type 1 and Polymorphism in the p1/p6 Gag Cleavage Site in Drug Resistance and Replication Fitness J. Virol. 80 (12), 6136-6145 (2006) 2.55e-51  
2
2PR
0 Case report(s) / study subset
Brehm (2011) Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase J. Acquir. Immune Defic. Syndr. 56 (4), 344-348 (2 0 105
105RT
106
106RT
99 HIVDB
Brehm (2012) Frequent Emergence of N348I in HIV-1 Subtype C Reverse Transcriptase with Failure of Initial Therapy Reduces Susceptibility to Reverse-Transcriptase Inhibitors Clin. Infect. Dis. (2012) In press 0 138
138RT
138
138RT
100 HIVDB
Brener (2015) Disease progression despite protective HLA expression in an HIV-infected transmission pair Retrovirology 12, 55 (2015) 0  
4
4PR
4RT
4IN
0 Case report(s) / study subset
Brennan (2009) Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors. Transfusion 0 65
62PR
62RT
3IN
65
62PR
62RT
3IN
100 HIVDB
Brennan (1997) GENETIC variation in human immunodeficiency virus type 2: identification of a unique variant from human plasma AIDS Res. Hum. Retroviruses 13 (5), 401-404 (1997) 6.26e-115 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Brennan (2007) HIV-1 Strains Identified in Brazilian Blood Donors: Significant Prevalence of B/F1 Recombinants AIDS Res. Hum. Retroviruses 23 (11), 1434-1441 (2007) 1e-167 82
82IN
85
85IN
96 HIVDB
Brennan (2009) The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004 J. Acquir. Immune Defic. Syndr. 49 (4), 432-439 (2 1e-166 572
572IN
573
1RT
573IN
99 HIVDB
Brennan (2011) Expanded evaluation of blood donors in the United States for human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains: 2005 through 2007 Transfusion 50 (12), 2707-2712 (2010) 0 203
203PR
203RT
203
203PR
203RT
100 HIVDB
Brenner (2006) HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture AIDS 20 (9), F9-F13 (2006) 0  
5
5PR
5RT
0 Laboratory/experimental isolate
Brenner (2006) HIGH Rates of Forward Transmission Events after Acute/Early HIV-1 Infection J. Infect. Dis. 195 (7), 951-959 (2007) 0  
38
38PR
38RT
0 Case report(s) / study subset
Brenner (2010) HIV-1 Integrase Genotypic Analysis: Implications in the Study of HIV-1 Drug Resistance and Subtype Diversification Antimicrob. Agents Chemother. (2010) In press 0 8
8IN
8
8PR
8RT
8IN
100 HIVDB
Brenner (2010) Transmission networks of drug resistance acquired in primary/early stage HIV infection AIDS 22 (18), 2509-2515 (2008) 1.18e-146  
4
4PR
4RT
0 ARV Rx and/or other data are N/A
Brenner (2011) Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors J. Med. Virol. 83 (5), 751-759 (2011) 1e-167 149
149IN
149
149IN
100 HIVDB
Brenner (2011) Spread of HIV-1 Drug-Resistant Sub-epidemics Unpublished 0  
1
1PR
1RT
0 Case report(s) / study subset
Brenner (2011) Transmission Clustering Drives the Onward Spread of the HIV Epidemic Among Men Who Have Sex With Men in Quebec J. Infect. Dis. 204 (7), 1115-1119 (2011) 0  
215
215PR
215RT
0 Case report(s) / study subset
Brenner (2016) HIV-1strains associated with large cluster networks show accelerated escape from integrase inhibitors Unpublished 0  
8
8IN
0 Case report(s) / study subset
Brenner (2016) Case Study of Dolutegravir Escape in First-Line Therapy through Acquisition of G118R in HIV-1 Integrase Unpublished 0 1
1IN
1
1IN
100 HIVDB
Brenner (2017) Human immunodeficiency virus type 1 strains associated with large cluster transmissions show rapid escape from integrase inhibitors in cell culture Unpublished 0  
9
9IN
0 Unpublished
Brigido (2005) SHORT Communication: Molecular Characteristics of HIV Type 1 Circulating in Sao Paulo, Brazil AIDS Res. Hum. Retroviruses 21 (7), 673-682 (2005) 0  
251
125PR
126RT
0 Pending
Brigido (2008) HIV type 1 subtype C and CB Pol recombinants prevail at the cities with the highest AIDS prevalence rate in Brazil AIDS Res. Hum. Retroviruses 23 (12), 1579-1586 (2007) 0 321
185PR
195RT
322
186PR
196RT
99 HIVDB
Brigido (2010) Southern Brazil HIV Type 1 C Expansion into the State of Sao Paulo, Brazil AIDS Res. Hum. Retroviruses 27 (3), 339-344 (2011) 0 232
221PR
221RT
684
457PR
471RT
15IN
33 HIVDB
Brindeiro (1999) SEQUENCE diversity of the reverse transcriptase of human immunodeficiency virus type-1 from Brazilian untreated individuals Antimicrob. Agents Chemother. (1999) In press 2e-91 18
18RT
18
18RT
100 HIVDB
Brindeiro (2003) BRAZILIAN Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals AIDS 17 (7), 1063-1069 (2003) 1e-145 350
199PR
191RT
357
199PR
199RT
98 HIVDB
Briones (2000) DYNAMICS of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy Virus Res. 66 (1), 13-26 (2000) 1e-128  
186
180PR
186RT
0 Evolution/quasispecies study
Briones (2003) MEMORY in retroviral quasispecies: experimental evidence and theoretical model for human immunodeficiency virus J. Mol. Biol. 331 (1), 213-229 (2003) 1e-126  
15
15PR
15RT
0 Evolution/quasispecies study
Brockman (2012) Uncommon Pathways of Immune Escape Attenuate HIV-1 integrase Replication Capacity J. Virol. 86 (12), 6913-6923 (2012) 1e-167 88
88IN
88
88IN
100 HIVDB
Brooks (2013) Local phylogenetic analysis identifies distinct trends in transmitted HIV drug resistance: implications for public health interventions BMC Infect. Dis. 13 (1), 509 (2013) 2.37e-163 274
274PR
274RT
274
274PR
274RT
100 HIVDB
Brooks (2016) Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya J Int AIDS Soc 19 (1), 20798 (2016) 1.67e-168 35
35RT
35
35RT
100 HIVDB
Brown (2009) Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous epidemiological definitions J. Infect. Dis. 199 (3), 427-431 (2009) 0 165
165PR
165RT
165
165PR
165RT
100 HIVDB
Brown (1999) SEQUENCE clusters in human immunodeficiency virus type 1 reverse transcriptase are associated with subsequent virological response to antiretroviral therapy J. Infect. Dis. 180 (4), 1043-1049 (1999) 1e-130  
55
55PR
55RT
0 DNAChip
Brown (2005) BIOLOGIC and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines J. Virol. 79 (10), 6089-6101 (2005) 0 21
21PR
21RT
21IN
21
21PR
21RT
21IN
100 HIVDB
Brumme (2007) EVIDENCE of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1 PLoS Pathog. 3 (7), E94 (2007) 0 1054
824PR
824RT
1055
825PR
824RT
99 HIVDB
Brumme (2009) HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins PLoS ONE 4 (8), E6687 (2009) 0 1661
683PR
1059RT
976IN
1667
689PR
1078RT
1129IN
99 HIVDB
Bruner (2016) Defective proviruses rapidly accumulate during acute HIV-1 infection Nat. Med. (2016) In press 0  
207
107PR
181RT
160IN
0 Evolution/quasispecies study
Bruselles (2009) Use of massive parallel pyrosequencing for near full-length characterization of a unique HIV BF recombinant associated with a fatal primary infection AIDS Res Hum Retroviruses. 2009 Sep;25(9):937-42. 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Bruzzone (2015) Prevalence of HIV-1 subtypes and drug resistance associated mutations in HIV-1 positive treatment-naive pregnant women in Pointe Noire, Republic of the Congo (Kento-Mwana project) AIDS Res. Hum. Retroviruses (2015) In press 2.68e-144 1
1PR
1RT
1
1PR
1RT
100 HIVDB
Bruzzone (2015) Prevalence of HIV-1 Subtypes and Drug Resistance-Associated Mutations in HIV-1-Positive Treatment-Naive Pregnant Women in Pointe Noire, Republic of the Congo (Kento-Mwana Project) AIDS Res. Hum. Retroviruses 31 (8), 837-840 (2015) 3.15e-147 36
36PR
36RT
36
36PR
36RT
100 HIVDB
Bruzzone (2016) Impact of extensive HIV-1 variability on molecular diagnosis in the Congo basin J. Clin. Virol. 47 (4), 372-375 (2010) 3.85e-134 1
1PR
1RT
1
1PR
1RT
100 HIVDB
Buckheit (2012) Long-term control of viral replication in a Group O, human immunodeficiency virus type 1-infected individual. AIDS Res Hum Retroviruses. 2014 Jun;30(6):511-3. 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Buckheit (2012) Host Factors Dictate Control of Viral Replication in two HIV-1 Controller/Chronic Progressor Transmission Pairs Nat Commun (2012) In press 0  
4
4PR
4RT
4IN
0 Case report(s) / study subset
Buckheit (2013) Evolution of an attenuated HIV-1 isolate in an elite suppressor. AIDS Res Hum Retroviruses. 2014 Mar;30(3):284-8. 0  
3
3PR
3RT
3IN
0 Case report(s) / study subset
Buckton (2008) DEVELOPMENT and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance J. Antimicrob. Chemother. 62 (6), 1191-1198 (2008) 0  
24
17PR
24RT
0 Case report(s) / study subset
Budambula (2015) HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users AIDS Res Ther 12, 27 (2015) 3e-63 132
132PR
132
132PR
100 HIVDB
Bui (2016) Proviruses with Identical Sequences Comprise a Large Fraction of the Replication-Competent HIV Reservoir Unpublished 0  
2477
2363PR
2477RT
220IN
0 Unpublished
Bui (2017) Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells Unpublished 0  
1576
1576PR
1576RT
0 New
Bui (2017) Proviruses with Identical Sequences Comprise a Large Fraction of the Replication-Competent HIV Reservoir Unpublished 0  
882
676PR
878RT
445IN
0 New
Bui (2017) Clonal Proviruses Comprise a Large Fraction of the Replication-Competent HIV Reservoir Unpublished 0  
166
53PR
166RT
166IN
0 New
Bulgheroni (2001) UNUSUAL codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility J. Clin. Virol. 29 (1), 27-32 (2004) 4e-77  
3
3RT
0 Case report(s) / study subset
Buonaguro (2006) SCREENING of HIV-1 isolates by reverse heteroduplex mobility assay and identification of non-B subtypes in Italy J. Acquir. Immune Defic. Syndr. 37 (2), 1295-1306 (2004) 0  
3
3PR
3RT
3IN
0 Case report(s) / study subset
Buranapraditkun (2011) Viral Escape from a Novel Immunodominant HLA-Cw*0102-Restricted Gag Epitope in HIV-1 Clade A/E Infection Unpublished 0.006  
2
2PR
0 Gene fragment(s)
Burda (2005) HIV-1 CRF09_cpx circulates in the North West Province of Cameroon where CRF02_AG infections predominate and recombinant strains are common AIDS Res. Hum. Retroviruses 20 (12), 1358-1363 (2004) 2.19e-57  
20
20PR
0 Sequence quality
Burda (2009) HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naive to HAART in Cameroon J. Med. Virol. 82 (2), 187-196 (2010) 0 49
49RT
49
49RT
100 HIVDB
Bure (2011) Genetic analysis of pol gene of HIV-1 in Indian children Unpublished 2e-60  
13
13PR
13RT
0 Case report(s) / study subset
Burkala (2005) COMPARTMENTALIZATION of HIV-1 in the central nervous system: role of the choroid plexus AIDS 19 (7), 675-684 (2005) 1e-152  
140
140PR
140RT
0 Evolution/quasispecies study
Burns (2005) SEQUENCE variability of the integrase protein from a diverse collection of HIV type 1 isolates representing several subtypes AIDS Res. Hum. Retroviruses 18 (14), 1031-1041 (2002) 1e-159 21
21IN
21
21IN
100 HIVDB
Bussmann (2005) HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana. Antivir Chem Chemother 0 71
71PR
71RT
71
71PR
71RT
100 HIVDB
Buzon (2008) Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy. Antivir Ther 1e-167 123
123IN
135
135IN
91 HIVDB
Buzon (2011) Combined antiretroviral therapy and immune pressure lead to in vivo HIV-1 recombination with ancestral viral genomes J. Acquir. Immune Defic. Syndr. (2011) In press 6.36e-146  
72
36PR
36RT
0 Evolution/quasispecies study
Bychenko (2009) Isolation, characterization, and sequence analysis of a novel HIV type 1 subtype A1 strain from Russia. AIDS Res Hum Retroviruses. 2012 Sep;28(9):1139-46. 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Byrn (2006) HIV-1 in semen: an isolated virus reservoir Lancet 350 (9085), 1141 (1997) 5e-58  
37
37PR
0 Case report(s) / study subset
Cabana (1999) EMERGENCE and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors J. Med. Virol. 59 (4), 480-490 (1999) 1e-125 92
54PR
38RT
92
54PR
38RT
100 HIVDB
Caetano (2013) Epidemiological and molecular profile of HIV infection among female sex workers in central Brazil Unpublished 5.1e-169  
4
4PR
4RT
0 Case report(s) / study subset
Calazans (2003) LOW Accumulation of L90M in Protease from Subtype F HIV-1 with Resistance to Protease Inhibitors Is Caused by the L89M Polymorphism J. Infect. Dis. 191 (11), 1961-1970 (2005) 1e-126 51
51PR
51RT
52
52PR
51RT
98 HIVDB
Cali (2004) EVIDENCE for host-driven selection of the HIV type 1 vpr gene in vivo during HIV disease progression in a transfusion-acquired cohort AIDS Res. Hum. Retroviruses 21 (8), 728-733 (2005) 0  
15
15PR
15RT
15IN
0 Case report(s) / study subset
Calugi (2006) ENTIRE Genome of a Strain of Human Immunodeficiency Virus Type 1 with a Deletion of nef That Was Recovered 20 Years after Primary Infection: Large Pool of Proviruses with Deletions of env J. Virol. 80 (23), 11892-11896 (2006) 0  
1
1PR
1RT
1IN
0 Sequence quality
Calvez (2002) IMPACT of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial Antivir. Ther. (Lond.) 7 (3), 211-218 (2002) 2e-94  
26
26RT
0 ARV Rx and/or other data are N/A
Candotti (1999) AIDS in an HIV-seronegative Ghanaian woman with intersubtype A/G recombinant HIV-1 infection J. Med. Virol. 62 (1), 1-8 (2000) 1e-165  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Canducci (2008) Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies. AIDS 1e-154 37
37IN
37
37IN
100 HIVDB
Canducci (2011) Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir J. Infect. Dis. 204 (11), 1811-1815 (2011) 1e-167 38
38IN
38
38IN
100 HIVDB
Capel (2012) Evolution of the human immunodeficiency virus type 1 protease: effects on viral replication capacity and protease robustness J. Gen. Virol. 93 (PT 12), 2625-2634 (2012) 1e-59  
21
21PR
0 ARV Rx and/or other data are N/A
Capel (2013) Significant changes in integrase-associated HIV-1 replication capacity between early and late isolates Virology 444 (1-2), 274-281 (2013) 0 94
94IN
94
94IN
100 HIVDB
Caplinskas (2012) Distinct HIV-1 strains in different risk groups and the absence of new infections by drug-resistant strains in Lithuania AIDS Res. Hum. Retroviruses (2012) In press 0 27
27PR
27RT
27
27PR
27RT
100 HIVDB
Caragounis (2008) Comparison of HIV-1 pol and env sequences of blood, CSF, brain and spleen isolates collected ante-mortem and post-mortem Acta Neurol. Scand. 117 (2), 108-116 (2008) 2.08e-148  
56
28PR
28RT
0 Evolution/quasispecies study
Cardoso (2009) HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naive patients from Central West Brazil J. Clin. Virol. 46 (2), 134-139 (2009) 5.54e-178 97
97PR
97RT
97
97PR
97RT
100 HIVDB
Cardoso (2009) High level of multidrug resistance mutations in HIV type 1 pol gene and resistance-associated mutations to enfuvirtide (T-20) among antiretroviral-experienced patients from central Brazil AIDS Res. Hum. Retroviruses 25 (10), 943-950 (2009 1.18e-172 48
48PR
48RT
48
48PR
48RT
100 HIVDB
Cardoso (2010) HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil J. Med. Virol. 82 (3), 351-357 (2010) 1.13e-175  
77
77PR
77RT
0 Pending
Cardoso (2011) Molecular Characteristics of HIV Type 1 Infection Among Prisoners from Central Western Brazil AIDS Res. Hum. Retroviruses (2011) In press 2.97e-175  
27
27PR
27RT
0 Case report(s) / study subset
Caride (2000) DRUG-RESISTANT reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART Virology 275 (1), 107-115 (2000) 5e-89  
14
14RT
0 ARV Rx and/or other data are N/A
Caride (2001) GENOTYPIC and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART Virus Genes 23 (2), 193-202 (2001) 1e-123 14
14PR
28
28PR
50 HIVDB
Carlson (2014) HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck Science 345 (6193), 1254031 (2014) 0  
868
868PR
868RT
868IN
0 Evolution/quasispecies study
Carlson (2016) Transmitted and de novo cellular immune escape drive HIV-1 disease progression Unpublished 0  
64
64PR
64RT
0 Evolution/quasispecies study
Carneiro-Proietti (1997) DIRECT Submission Submitted (14-NOV-1996) Lab. Virus, Dept. Microbiologia, Uni 1e-128  
1
1PR
0 Case report(s) / study subset
Caron (2008) HUMAN immunodeficiency virus type 1 seroprevalence and antiretroviral drug resistance-associated mutations in miners in Gabon, central Africa AIDS Res. Hum. Retroviruses 24 (9), 1225-1228 (2008) 1.04e-134 40
21PR
19RT
40
21PR
19RT
100 HIVDB
Caron (2011) Increasing HIV-1 Polymorphism Diversity and Resistance to Antiretroviral Drugs in Untreated Pregnant Women from Gabon, central Africa Unpublished 0 103
101PR
96RT
103
101PR
103RT
100 HIVDB
Caron (2011) Increasing HIV-1 Genetic Diversity and Resistance to Antiretroviral Drugs among Untreated Pregnant Women from Gabon, Central Africa Unpublished 5.19e-57 3
3PR
3
3PR
3RT
100 HIVDB
Caron (2012) Increasing Genetic Diversity of HIV-1 and Resistance to Antiretroviral Drugs among Untreated Pregnant Women in Gabon, central Africa Unpublished 1.38e-159 1
1PR
1RT
1
1PR
1RT
100 HIVDB
Carr (1996) Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand J. Virol. 70 (9), 5935-5943 (1996) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Carr (1998) FULL genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants Virology 247 (1), 22-31 (1998) 1e-164 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Carr (1999) CHARACTERIZATION of subtype A HIV-1 from Africa by full genome sequencing AIDS 13 (14), 1819-1826 (1999) 1e-166 7
7PR
7RT
7IN
7
7PR
7RT
7IN
100 HIVDB
Carr (1999) DIRECT Submission Submitted (07-JUL-1998) Molecular Epidemiology, Henry M. Jac 1e-164 4
4PR
4RT
4IN
4
4PR
4RT
4IN
100 HIVDB
Carr (2001) THE AG Recombinant IbNG and Novel Strains of Group M HIV-1 are Common in Cameroon Virology (2001) In press 0 7
7PR
7RT
7IN
8
8PR
8RT
8IN
87 Laboratory/experimental isolate
Carr (2001) DIVERSE BF recombinants have spread widely since the introduction of HIV-1 into South America AIDS 15 (15), F41-F47 (2001) 1e-165 21
21PR
21RT
21IN
21
21PR
21RT
21IN
100 HIVDB
Carr (2004) OUTBREAK of a West African recombinant of HIV-1 in Tashkent, Uzbekistan J. Acquir. Immune Defic. Syndr. 39 (5), 570-575 (2005) 0 239
233PR
232RT
12IN
246
246PR
246RT
12IN
97 HIVDB
Carr (2005) HIV Subtype and Drug Resistance Patterns among Drug Naive Persons in Jos, Nigeria Unpublished 0 23
23PR
23RT
7IN
23
23PR
23RT
7IN
100 HIVDB
Carr (2006) HIGH Genetic Complexity of HIV-1 in low-prevalence, rural regions of Cameroon Unpublished 0 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Carr (2008) IDENTIFICATION of CRF17_BF in Four South American Countries Unpublished 0 6
6PR
6RT
6IN
6
6PR
6RT
6IN
100 HIVDB
Carr (2010) HIV-1 Recombinants with Multiple Parental Strains in Low-Prevalence, Remote Regions of Cameroon Retrovirology. 2010 Apr 28;7:39. 0 24
24PR
23RT
24IN
24
24PR
24RT
24IN
100 HIVDB
Carr (2016) Isolation of a Simian Immunodeficiency Virus from the Malbrouck (Chlorocebus cynosuros) Unpublished 0  
1
1PR
1RT
1IN
0 NHPL/SIV
Carrera (2010) Identification of unusual and novel HIV type 1 spliced transcripts generated in vivo AIDS Res. Hum. Retroviruses 26 (7), 815-820 (2010) 2.11e-31  
2
1RT
1IN
0 Gene fragment(s)
Carrion (2002) CIRCULATING Recombinant Form CRF02_AG in South America AIDS Res. Hum. Retroviruses 19 (4), 329-332 (2003) 1e-163 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Carrion (2004) DOCUMENTATION of subtype C HIV Type 1 strains in Argentina, Paraguay, and Uruguay AIDS Res. Hum. Retroviruses 20 (9), 1022-1025 (2004) 0 2
2PR
2RT
2IN
7
7PR
7RT
2IN
28 HIVDB
Carrion (2009) Molecular characterization of the human immunodeficiency virus type 1 among children in Lima, Peru AIDS Res. Hum. Retroviruses (2009) In press 1e-173  
2
2PR
2RT
0 Case report(s) / study subset
Carvalho (2010) Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland north state of Tocantins, Brazil. ARHR 1.51e-178 52
52PR
52RT
60
60PR
60RT
86 HIVDB
Carvalho (2015) Analysis of a Local HIV-1 Epidemic in Portugal Highlights Established Transmission of non-B and -G Subtypes Unpublished 6.4e-147 16
16PR
15RT
16
16PR
16RT
100 HIVDB
Carvalho (2015) Analysis of a Local HIV-1 Epidemic in Portugal Highlights Established Transmission of Non-B and Non-G Subtypes J. Clin. Microbiol. 53 (5), 1506-1514 (2015) 3.89e-149 273
273PR
271RT
273
273PR
273RT
100 HIVDB
Casado (2003) NEAR Full-Length Genome Characterization of an HIV Type 1 CRF05_DF Virus from Spain AIDS Res. Hum. Retroviruses 19 (8), 719-725 (2003) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Casado (2007) IDENTIFICATION of a novel HIV-1 circulating ADG intersubtype recombinant form (CRF19_cpx) in Cuba J. Acquir. Immune Defic. Syndr. 40 (5), 532-537 (2005) 0 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Castelbranco (2010) Frequency of Primary Resistance to Antiretroviral Drugs and Genetic Variability of HIV-1 Among Infected Pregnant Women Recently Diagnosed in Luanda-Angola AIDS Res. Hum. Retroviruses 26 (12), 1313-1316 (20 2.61e-145 35
35PR
35RT
35
35PR
35RT
100 HIVDB
Castillo (2009) Surveillance of HIV Type 1 Drug Resistance among Naive Patients from Venezuela AIDS Res. Hum. Retroviruses (2009) In press 4e-173 133
68PR
65RT
133
68PR
65RT
100 HIVDB
Castley (2015) Direct Submission Submitted (01-JUL-2015) Department of Clinical Imm 5.7e-146 1022
1022PR
1022RT
1024
1024PR
1024RT
99 HIVDB
Castro (2002) MOLECULAR epidemiology of HIV-1 in Venezuela: high prevalence of HIV-1 subtype B and identification of a B/F recombinant infection J. Acquir. Immune Defic. Syndr. 32 (3), 338-344 (2003) 7e-77  
2
1PR
1RT
0 Case report(s) / study subset
Castro (2004) BODY Compartments Follow-up & HIV-1 Mosaic Genome Definition. E7109254 (in) EXTENDED ABSTRACT BOOK, XV INTERNATIONAL AIDS CONFERENC 1e-135  
4
4RT
0 Case report(s) / study subset
Castro (2004) RESISTANCE mutations and molecular characterization of HIV-1 isolates from Venezuelan patients with virological failure Unpublished 1e-136  
41
20PR
29RT
0 ARV Rx and/or other data are N/A
Castro (2004) Resistence mutations and molecular characterization of HIV-1 isolates from Venezuelan patients with virological failure Unpublished 2.11e-46  
1
1PR
0 Case report(s) / study subset
Castro (2005) Trends of HIV-1 molecular epidemiology in Venezuela: introduction of subtype C and identification of a novel B/C mosaic genome J. Clin. Virol. 32 (3), 257-258 (2005) 1.37e-148  
3
3RT
0 Gene fragment(s)
Castro (2006) Highly conserved HIV-1 subtype B strains circulating in Honduras (in) 3RD IAS CONFERENCE ON HIV PATHOGENESIS AND TR 3.72e-140  
6
3PR
3RT
0 Case report(s) / study subset
Castro (2009) HIV-1 transmission network of 103N resistance mutation in Southwest Switzerland AIDS Res Hum Retroviruses. 2010 Sep 23. [Epub ahead of print 0 19
19PR
19RT
19
19PR
19RT
100 HIVDB
Castro (2010) HIV-1 Drug Resistance Transmission Networks in Southwest Switzerland AIDS Res. Hum. Retroviruses 26 (11), 1233-1238 (20 4e-170 11
11PR
11RT
11
11PR
11RT
100 HIVDB
Caumont (2001) Sequence analysis of env C2/V3, gag p17/p24, and pol protease regions of 25 HIV type 1 isolates from Ho Chi Minh city, Vietnam. ARHR 9e-98 26
24PR
2RT
27
25PR
2RT
96 HIVDB
Cavaco-Silva (2014) HIV-2 Integrase Polymorphisms and Longitudinal Genotypic Analysis of HIV-2 Infected Patients Failing a Raltegravir-Containing Regimen PLoS ONE 9 (3), E92747 (2014) 2e-128 79
79IN
83
83IN
95 HIVDB
Ceballos (2016) HIV dual infection with subtype B and BF recombinants in Argentina Unpublished 5e-137  
1
1PR
1RT
0 Case report(s) / study subset
Ceccherini-Silberstein (2005) IDENTIFICATION of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure AIDS 18 (12), F11-F19 (2004) 0  
479
479PR
479RT
0 Pending
Ceccherini-Silberstein (2006) HIGH sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations J. Virol. 79 (16), 10718-10729 (2005) 0  
178
178PR
178RT
0 Pending
Ceccherini-Silberstein (2007) IMPACT of HIV-1 Reverse Transcriptase Polymorphism F214L on Virological Response to Thymidine Analogue-Based Regimens in Antiretroviral Therapy (ART)-Naive and ART-Experienced Patients J. Infect. Dis. 196 (8), 1180-1190 (2007) 0  
674
673PR
674RT
0 Pending
Ceccherini-Silberstein (2007) CHARACTERIZATION and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors J. Virol. 81 (20), 11507-11519 (2007) 0  
75
75PR
75RT
0 ARV Rx and/or other data are N/A
Ceccherini-Silberstein (2010) Secondary Integrase Resistance Mutations Found in HIV-1 Minority Quasispecies in Integrase Therapy-Naive Patients Have Little or No Effect on Susceptibility to Integrase Inhibitors Antimicrob. Agents Chemother. 54 (9), 3938-3948 (2 0  
458
433RT
457IN
0 Evolution/quasispecies study
Cenci (1997) SELECTED nucleotide sequence of the pol gene of the monocytotropic strain HIV type 1 BaL AIDS Res. Hum. Retroviruses 13 (7), 629-632 (1997) 5e-49  
1
1RT
0 Case report(s) / study subset
Cenci (2003) LOW Intra-Host Diversity in HIV-1 Protease Gene in Untreated Primary Infection: a Crucial Role for Purifying Selection Unpublished 1e-126  
67
67PR
0 Evolution/quasispecies study
Cenci (2004) HIV-1 pol genotype divergence in the plasma and cerebrospinal fluid (CSF) of untreated patients in acute and chronic infection Unpublished 7.57e-129  
62
44PR
18RT
0 Unpublished
Chabadova (2014) Direct Submission Submitted (21-FEB-2014) NRC for HIV AIDS Preventio 7.76e-111  
144
16PR
143RT
0 Gene fragment(s)
Chaillon (2017) Spatiotemporal dynamics of HIV-1 transmission in France (1999-2014) and impact of targeted prevention strategies Retrovirology 14 (1), 15 (2017) 0  
342
342RT
0 New
Chaix (2003) Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. AIDS 1e-116 244
244RT
244
244RT
100 HIVDB
Chakrabarti (1999) SEQUENCE of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses Nature 328 (6130), 543-547 (1987) 1e-98  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Chakrabarti (2011) HIV-1 recombinants among Maipur IDUs Unpublished 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Chakraborty (2003) FAILURE to detect human immunodeficiency virus type 1 superinfection in 28 HIV-seroconcordant individuals with high risk of reexposure to the virus AIDS Res. Hum. Retroviruses 20 (9), 1026-1031 (2004) 0  
162
81PR
81RT
0 Evolution/quasispecies study
Chakraborty (2003) CAN HIV-1 superinfection compromise antiretroviral therapy? AIDS 18 (1), 132-134 (2004) 2e-87  
8
8RT
0 Case report(s) / study subset
Chaloin (2004) ANTIVIRAL activity of reverse trancriptase inhibitors with different HIV strains and isolates Unpublished 0  
14
14RT
8IN
0 ARV Rx and/or other data are N/A
Chamberland (2011) Transmission of HIV-1 drug resistance in Benin could jeopardise future treatment options. Sex Transm Infect 0 127
127PR
127RT
127
127PR
127RT
100 HIVDB
Chamberland (2016) Characterization of drug resistance in a cohort of subjects on antiretroviral therapy infected with HIV-1 CRF02_AG and AGK subtypes in Mali and Burkina Faso Unpublished 2.22e-158 1
1PR
1RT
1
1PR
1RT
100 HIVDB
Chang (2008) Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan. J Antimicrob Chemother 6.74e-167 3
3PR
3RT
3
3PR
3RT
100 HIVDB
Chang (2015) Direct Submission Submitted (27-MAY-2015) Academy of Military Medica 0  
2
2RT
0 Case report(s) / study subset
Chang (2016) Direct Submission Submitted (06-NOV-2015) AIDS Research, Institute o 0 478
434PR
478RT
59IN
478
442PR
478RT
61IN
100 HIVDB
Chang (2016) Direct Submission Submitted (27-MAR-2015) AIDS Research, Beijing Ins 0  
17
17RT
0 Unpublished
Chang (2006) MOLECULAR Epidemiology of HIV Type 1 Subtypes in Taiwan: Outbreak of HIV Type 1 CRF07)BC Infection in Intravenous Drug Users AIDS Res. Hum. Retroviruses 22 (11), 1055-1066 (2006) 1.63e-166 152
152PR
152RT
152
152PR
152RT
100 HIVDB
Chang (2014) Slow immunological progression in injecting drug users infected with human immunodeficiency virus type 1 CRF07_BC in Taiwan Unpublished 0 122
122PR
122RT
1IN
127
127PR
127RT
1IN
96 HIVDB
Chang (2016) Molecular Epidemiology of HIV Type 1 Subtypes in Taiwan: Outbreak of HIV Type 1 CRF07_BC Infection in Intravenous Drug Users Unpublished 2.22e-165 3
3PR
3RT
3
3PR
3RT
100 HIVDB
Chang (2000) DIFFERENTIAL stability of the mRNA secondary structures in the frameshift site of various HIV type 1 viruses AIDS Res. Hum. Retroviruses 15 (17), 1591-1596 (1999) 1e-163  
5
5PR
5RT
5IN
0 Case report(s) / study subset
Chang (2000) SEQUENCE features downstream of the primer-binding site of HIV type 1 subtype E shared by subtype G and a subset of subtype A AIDS Res. Hum. Retroviruses 15 (18), 1703-1706 (1999) 1e-163  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Chantratita (1999) HIV-1 resistant to antiretroviral drugs in Thailand Unpublished 1e-128 26
26PR
26RT
722
342PR
469RT
3 ARV Rx and/or other data are N/A
Chantratita (2005) Prevalence of mutations related to HIV-1 antiretroviral drug resistance in Thailand, 2003 Unpublished 2.48e-143 784
331PR
453RT
784
331PR
453RT
100 HIVDB
Chantratita (2016) Prevalence of primary HIV drug resistance with short reverse transcriptase genotypic resistance assay for the detection of primary HIV drug resistance in Thailand Unpublished 3.83e-64  
307
307RT
0 Gene fragment(s)
Chaplin (2011) Impact of HIV Type 1 Subtype on Drug Resistance Mutations in Nigerian Patients Failing First-Line Therapy AIDS Res. Hum. Retroviruses 27 (1), 71-80 (2011) 1e-168 2
2PR
2RT
2
2PR
2RT
100 HIVDB
Charpentier (2009) Prevalence of HIV-1 drug resistance in HIV-1 infected patients treated in Douala, Cameroon Unpublished 0 56
54PR
56RT
56
54PR
56RT
100 HIVDB
Charpentier (2011) High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger. Antivir Ther 7e-173 47
47RT
47
47RT
100 HIVDB
Charpentier (2011) Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir. Antimicrob Agents Chemother. 2011 Mar;55(3):1293-5. 1e-100 11
11IN
12
12IN
91 HIVDB
Charpentier (2011) Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen Unpublished 1e-166 33
12PR
12RT
9IN
33
12PR
12RT
9IN
100 HIVDB
Charpentier (2014) Genotypic resistance profiles of HIV-2-treated patients in Cote d'Ivoire, West Africa Unpublished 1.36e-146 52
27PR
25RT
55
29PR
25RT
1IN
94 HIVDB
Charpentier (2016) High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger Unpublished 2.86e-169 140
140RT
140
140RT
100 HIVDB
Chaturbhuj (2010) Transmitted HIV drug resistance among HIV-infected voluntary counseling and testing centers (VCTC) clients in Mumbai, India. ARHR 0 34
34PR
34RT
34
34PR
34RT
100 HIVDB
Chehadeh (2013) HIV drug resistance in Kuwait Unpublished 2.31e-151 28
14PR
14RT
28
14PR
14RT
100 HIVDB
Chehadeh (2014) HIV-1 subtypes and drug resistance profile in Kuwait Unpublished 5e-59 8
8PR
8
8PR
100 HIVDB
Chehadeh (2016) Phylogenetic analysis of HIV-1 subtypes and drug resistance profile among treatment-naive people in Kuwait J. Med. Virol. 87 (9), 1521-1526 (2015) 0 24
8PR
16RT
86
70PR
78RT
27 HIVDB
Chen (2015) HIV drug resistance and antiretroviral drug detection in HIV-infected Black men who have sex with men: HIV Prevention Trials Network 061 Unpublished 0  
192
192PR
192RT
0 ARV Rx and/or other data are N/A
Chen (2010) Near full-length genomic characterization of a novel HIV-1 CRF07_ BC/CRF08_ BC recombinant strain from Yunnan, China AIDS Res. Hum. Retroviruses (2010) In press 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Chen (2012) Low Prevalence of Drug Resistance and Genetic Diversity among Newly HIV-1 Diagnosed Individuals from 2009 to 2010 in Western Yunnan, China Unpublished 0 122
122PR
122RT
122
122PR
122RT
100 HIVDB
Chen (2013) Genetic diversity and drug resistance among newly diagnosed and antiretroviral treatment-naive HIV-infected individuals in western Yunnan: a hot area of viral recombination in China BMC Infect. Dis. 12, 382 (2012) 0 177
177PR
177RT
177
177PR
177RT
100 HIVDB
Chen (2015) The Combination of Phylogenetic Analysis with Epidemiological and Serological Data to Track HIV-1 Transmission in a Sexual Transmission Case PLoS ONE 10 (3), E0119989 (2015) 0  
21
21PR
21RT
0 Case report(s) / study subset
Chen (2013) HIV-1 genotypes and drug resistance threshold survey in Honghe Prefecture of Yunnan Province in 2011 Unpublished 0 41
41PR
41RT
41
41PR
41RT
100 HIVDB
CHEN (2012) Molecular epidemiology and drug resistance of HIV type 1 in patients within late-stage infection in Guangdong province, China Unpublished 0  
179
179PR
179RT
0 Pending
Chen (2015) Changing subtype dominance and shift in resistance of HIV-1 in the southwest border of China Unpublished 0 285
284PR
285RT
285
285PR
285RT
100 HIVDB
Chen (2017) First description of two new HIV-1 recombinant forms CRF82_cpx and CRF83_cpx among drug users in Northern Myanmar Virulence (2016) In press 0  
31
31PR
31RT
31IN
0 New
Chen (2016) HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China PLoS ONE 11 (2), E0149215 (2016) 0  
30
30PR
30RT
0 Case report(s) / study subset
Chen (2017) Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan PLoS ONE 11 (12), E0167839 (2016) 0  
36
34PR
34RT
36IN
0 New
Chen (2015) Comprehensive Characterization of the Transmitted/founder env Genes from a Single MSM Cohort in China J. Acquir. Immune Defic. Syndr. (2015) In press 0  
293
23PR
23RT
293IN
0 Evolution/quasispecies study
Chen (2015) Comprehensive Characterization of the Transmitted/founder env Genes from a Single MSM Cohort in China J. Acquir. Immune Defic. Syndr. (2015) In press 0.000473  
1
1IN
0 Gene fragment(s)
Chen (1996) GENETIC characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop J. Virol. 70 (6), 3617-3627 (1996) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Cheng (1992) MOLECULAR characterization of HIV-2 (ROD) protease following PCR cloning from virus infected H9 cells Adv. Exp. Med. Biol. 312, 83-88 (1992) 2e-24  
1
1PR
0 Laboratory/experimental isolate
Chenhao (2015) High Proportion of CRF01_AE and Multiple Recombination Form Strains of HIV-1 Were Circulating in Suzhou and Suqian, Jiangsu Unpublished 5.1e-133  
32
32PR
32RT
0 Case report(s) / study subset
Cheong (2014) Cross-Border Sexual Transmission of the Newly Emerging HIV-1 Clade CRF51_01B PLoS ONE 9 (10), E111236 (2014) 0 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Cheong (2015) Genetic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF74_01B) Identified among Intravenous Drug Users in Malaysia: Recombination History and Phylogenetic Linkage with Previously Defined Recombinant Lineages PLoS ONE 10 (7), E0133883 (2015) 0 6
6PR
6RT
6IN
6
6PR
6RT
6IN
100 HIVDB
Cheong (2015) Genome sequence of complex HIV-1 unique recombinant forms (URFs) sharing common recombination breakpoint identified in Malaysia Unpublished 0  
3
3PR
3RT
3IN
0 Pending
Cheriro (2015) High Prevalence of HIV Low abundance Drug resistant variants in a treatment naive population in North Rift Kenya AIDS Res. Hum. Retroviruses (2015) In press 5.86e-168 59
55PR
59RT
59
55PR
59RT
100 HIVDB
Cheriro (2016) Drug resistance testing in HIV infected individuals on treatment and naive: Implications on treatment outcome J HIV Clin Sci Res 2 (2), 62-68 (2015) 0  
100
100PR
100RT
0 Pending
Chibo (2011) HIV Transmissions During Seroconversion Contribute Significantly to New Infections in Men Who Have Sex with Men in Australia AIDS Res. Hum. Retroviruses 28 (5), 460-464 (2012) 1.37e-177 209
209PR
209RT
209
209PR
209RT
100 HIVDB
Chikata (2013) Host-specific adaptation of HIV-1 subtype B in the Japanese population Unpublished 0 363
363PR
360RT
363IN
363
363PR
363RT
363IN
100 HIVDB
Chimukangara (2014) Drug Resistance Mutations from Whole Blood Proviral DNA among Patients on Antiretroviral Drugs in Zimbabwe Curr. HIV Res. (2014) In press 1.34e-141  
108
108RT
0 Unpublished
Chimukangara (2016) HIV drug resistance testing among patients failing second line antiretroviral therapy. Validation of an in-house sequencing method Unpublished 1.53e-165 25
25PR
25RT
48
48PR
48RT
52 HIVDB
Chimukangara (2016) Successful Sustainable Community Based ART in Rural Zimbabwe Unpublished 1.88e-139  
8
8RT
0 Unpublished
Chin (2009) Comparison of genotypic resistance mutations in treatment-naive HIV type 1-infected patients in Korea and China. ARHR 0 64
64PR
64RT
64
64PR
64RT
100 HIVDB
Chin (2006) INVERSE Relationship between Viral Load and Genotypic Resistance Mutations in Korean Patients with Primary HIV Type 1 Infections AIDS Res. Hum. Retroviruses 22 (11), 1142-1147 (2006) 1e-147 52
52PR
52RT
52
52PR
52RT
100 HIVDB
Chin (2007) EARLY identification of seronegative human immunodeficiency virus type 1 infection with severe presentation J. Clin. Microbiol. 45 (5), 1659-1662 (2007) 1e-143  
3
3PR
3RT
0 Case report(s) / study subset
Chin (2007) FACTORS Associated with Short-term Clinical Parameters after Genotypic Resistance Assay in Korean Patients with HIV-1 Subtype B Virologic Failure J Korean Med Sci. 2009 Dec;24(6):1031-7. Epub 2009 Nov 7. 1e-146  
40
40PR
40RT
0 Pending
Chin (2010) Comparison of genotypic resistance mutations in treatment-naive HIV type 1-infected patients in Korea and China AIDS Res. Hum. Retroviruses 26 (2), 217-221 (2010) 6e-171 12
12PR
12RT
12
12PR
12RT
100 HIVDB
Chin (2015) Increase of K103N Transmitted Drug Resistance in Korean HIV-1 Infected Patients: A Single Center Experience Unpublished 0 131
131PR
131RT
131
131PR
131RT
100 HIVDB
Chin (2010) Genetic analysis of a UNAIDS HIV type 1 from Brazil revealed an unexpected recombination pattern. AIDS Res Hum Retroviruses. 2010 Dec;26(12):1261-3. 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Cho (2005) Phylogenetic analysis of near full-length HIV type 1 genomic sequences from 21 Korean individuals. AIDS Res Hum Retroviruses. 2013 Apr;29(4):738-43. 0 11
11PR
11RT
11IN
11
11PR
11RT
11IN
100 HIVDB
Cho (2006) High frequency of grossly deleted nef genes in HIV-1 infected long-term slow progressors treated with Korean red ginseng. Curr HIV Res. 2006 Oct;4(4):447-57. 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 Case report(s) / study subset
Cho (2006) VARIATION of vif gene according to progression rate in Korean patients: association with KRG treatment Unpublished 0.02  
105
105IN
0 Gene fragment(s)
Cho (2006) HIV-1 Vif gene Unpublished 0.02  
75
75IN
0 Gene fragment(s)
Cho (2012) Association of high frequency of gross deletions in the pol and 5' LTR/gag genes with Korean red ginseng intake in HIV-1 infected individuals Unpublished 1e-167  
226
208RT
225IN
0 ARV Rx and/or other data are N/A
Cho (2012) Phylogenetic analysis of full-length pol gene from Korean hemophiliacs and plasma donors infected with Korean subclade B of HIV type 1 Unpublished 0  
36
31PR
36RT
0 Case report(s) / study subset
Cho (2012) Phylogenetic analysis of full-length Korean subclade of HIV-1 subtype B Unpublished 0 10
10PR
10RT
10IN
10
10PR
10RT
10IN
100 HIVDB
Cho (2013) Frequent genetic defects in long-term survivors for more than 26 years in the absence of antiretroviral therapy in Korea: its association with ginseng treatment Unpublished 0  
9
9PR
9RT
9IN
0 Case report(s) / study subset
Cho (2014) Near full-length sequences of HIV-1 in Korean infected with Korean subclade B Unpublished 0  
23
23PR
23RT
23IN
0 Evolution/quasispecies study
Cho (2016) Phylogenetic analysis of full-length env gene from 2 plasma donors and hemophiliacs infected with Korean subclade B of HIV type 1 Unpublished 0  
1
1PR
1RT
1IN
0 Case report(s) / study subset
Cho (2016) High frequency of gross deletion on pol gene Unpublished 0  
315
48PR
305RT
252IN
0 Unpublished
Cho (2016) Low frequency of registance mutation on ginseng based combination therapy Unpublished 0  
580
351PR
558RT
392IN
0 Unpublished
Cho (2008) HIGH Frequency of Gross Deletions in the 5' LTR and gag Regions in HIV Type 1-Infected Long-Term Survivors Treated with Korean Red Ginseng AIDS Res. Hum. Retroviruses 24 (2), 181-193 (2008) 4.68e-157  
30
29PR
2RT
1IN
0 Case report(s) / study subset
Cho (2014) Long term follow up of HIV-infected Korean haemophiliacs, after infection from a common source of virus Unpublished 0  
99
86PR
99RT
69IN
0 Evolution/quasispecies study
Cho (2001) LONG-TERM intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed Int. Immunopharmacol. 1 (7), 1295-1305 (2001) 4e-96 10
10RT
37
37RT
27 HIVDB
Cho (2002) FREQUENCY of mutations conferring resistance to nucleoside reverse transcriptase inhibitors in human immunodeficiency virus type 1-infected patients in Korea J. Clin. Microbiol. 40 (4), 1319-1325 (2002) 1e-118 6
6RT
23
6PR
22RT
26 HIVDB
Cho (2003) MOLECULAR epidemiologic study of a human immunodeficiency virus 1 outbreak in haemophiliacs B infected through clotting factor 9 after 1990 Vox Sang. 92 (2), 113-120 (2007) 0  
192
155PR
177RT
8IN
0 Evolution/quasispecies study
Cho (2005) FULL sequence of HIV type 1 Korean subtype B in an AIDS case with atypical seroconversion: TAAAA at TATA box AIDS Res. Hum. Retroviruses 21 (11), 961-964 (2005) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 Case report(s) / study subset
Cho (2006) HIGH frequency of grossly deleted nef genes in HIV-1 infected long-term slow progressors treated with Korean red ginseng Curr. HIV Res. 4 (4), 447-457 (2006) 0.02  
3
3IN
0 Case report(s) / study subset
Cho (2010) Phylogenetic analysis of full-length pol gene from Korean hemophiliacs and plasma donors infected with Korean subclade B of HIV-1 AIDS Res. Hum. Retroviruses (2010) In press 0  
200
179PR
200RT
162IN
0 Evolution/quasispecies study
Cho (2013) First Report on a T69-ins Insertion in CRF06_cpx HIV Type 1 AIDS Res. Hum. Retroviruses 29 (7), 1079-1084 (201 0  
41
34PR
41RT
14IN
0 Case report(s) / study subset
Cho (2013) Effects of Korean red ginseng and HAART on vif gene in 10 long-term slow progressors over 20 years: high frequency of deletions and G-to-A hypermutation Young Keol Evid Based Complement Alternat Med (2013) In press 0.039  
1
1IN
0 Gene fragment(s)
Choi (1997) HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant AIDS Res. Hum. Retroviruses 13 (4), 357-361 (1997) 1e-164 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Choi (2010) Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified single-round assay J. Clin. Virol. (2010) In press 0  
5
5PR
5RT
0 Case report(s) / study subset
Chourasia (2014) Prevalence of antiretroviral drug resistance mutations in HIV-1 infected patients in eastern India after second-line treatment failure Unpublished 3e-180  
18
18PR
18RT
0 Pending
Chow (2012) Genome Sequences of a Novel HIV-1 CRF53_01B Identified in Malaysia J. Virol. 86 (20), 11398-11399 (2012) 0 3
3PR
3RT
3IN
3
3PR
3RT
3IN
100 HIVDB
Chow (2013) Molecular Diversity of HIV-1 among People Who Inject Drugs in Kuala Lumpur, Malaysia: Massive Expansion of Circulating Recombinant Form (CRF) 33_01B and Emergence of Multiple Unique Recombinant Clusters PLoS ONE 8 (5), E62560 (2013) 0 128
114PR
112RT
128
126PR
112RT
100 HIVDB
Chow (2014) A newly emerging HIV-1 recombinant lineage (CRF58_01B) disseminating among people who inject drugs in Malaysia. PLoS One. 2014 Jan 22;9(1):e85250. 0 5
5PR
5RT
5IN
5
5PR
5RT
5IN
100 HIVDB
Chow (2014) A Newly Emerging HIV-1 Recombinant Lineage (CRF58_01B) Disseminating among People Who Inject Drugs in Malaysia PLoS ONE 9 (1), E85250 (2014) 0 1
1PR
1RT
1IN
1
1PR
1RT
1IN
100 HIVDB
Chow (2014) Genome Sequence of a Complex HIV-1 Unique Recombinant Form Involving CRF01_AE, Subtype B, and Subtype B' Identified in Malaysia Genome Announc 2 (2), e00139-14 (2014) 0  
1
1PR
1RT
1IN
0 Pending
Chow (2016) Extensive Genetic Diversity of HIV-1 in Incident and Prevalent Infections among Malaysian Blood Donors: Multiple Introductions of HIV-1 Genotypes from Highly Prevalent Countries PLoS ONE 11 (8), E0161853 (2016) 0 154
152PR
143RT
154
154PR
143RT
100 HIVDB
Chung (2015) Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya J. Acquir. Immune Defic. Syndr. 67 (3), 246-253 (2 3.38e-168 159
48PR
159RT
202
106PR
202RT
78 HIVDB
Church (2009) Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission. J Infect Dis 0 49
49PR
49RT
49
49PR
49RT
100 HIVDB
Church (2007) HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D AIDS Res. Hum. Retroviruses 23 (6), 764-768 (2007) 0 47
47PR
47RT
47
47PR
47RT
100 HIVDB
Ciccozzi (2005) MOLECULAR Diversity of HIV in Albania J. Infect. Dis. 192 (3), 475-479 (2005) 0 66
66PR
66RT
66
66PR
66RT
100 HIVDB
Ciccozzi (2007) THE HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries AIDS Res. Hum. Retroviruses 24 (6), 771-779 (2008) 6.96e-167 81
80PR
79RT
81
81PR
81RT
100 HIVDB
Ciccozzi (2010) Genetic Diversity of HIV-1 in Montenegro AIDS Res. Hum. Retroviruses (2010) In press 0  
32
32PR
32RT
0 ARV Rx and/or other data are N/A
Ciccozzi (2012) HIV-1 origin and transmission dynamics among different risk groups in Sardinia: molecular epidemiology within the close boundaries of an Italian island AIDS Res. Hum. Retroviruses (2012) In press 1.59e-100  
215
215RT
0 ARV Rx and/or other data are N/A
Ciccozzi (2014) Viral Sequence Analysis of HIV-Positive Women and Their Infected Children: Insight on the Timing of Infection and on the Transmission Network AIDS Res. Hum. Retroviruses 30 (10), 1010-1015 (20 4.01e-146  
33
33PR
33RT
0 Case report(s) / study subset
Ciccozzi (2016) An outbreak of HIV-1 subtype G among Italian IDUs Unpublished 5.38e-150  
14
14PR
14RT
0 Case report(s) / study subset
Cilla (2001) MOLECULAR evidence of homosexual transmission of HIV type 2 in Spain AIDS Res. Hum. Retroviruses 17 (5), 417-422 (2001) 0.00007  
4
4RT
0 Case report(s) / study subset
Cinque (2001) EFFECT of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid AIDS Res. Hum. Retroviruses 17 (5), 377-383 (2001) 1e-129 33
15PR
18RT
57
24PR
33RT
57 HIVDB
Claassen (2009) Direct Submission Submitted (16-NOV-2007) NHLS/University of Stellen 7e-173  
150
150RT
0 Pending
Clarke (2005) REVERSE transcriptase and protease sequences from HIV-1 non-subtype B infected persons in the United Kingdom Unpublished 0 296
140PR
156RT
519
363PR
379RT
57 HIVDB
Clarke (2016) Reverse transcriptase and protease sequences from HIV-1 non subtype B infected persons in the United Kingdom Unpublished 2.19e-57 15
15PR
16
16PR
93 HIVDB
Clavel (1996) MOLECULAR cloning and polymorphism of the human immune deficiency virus type 2 Nature 324 (6098), 691-695 (1986) 1e-98 1
1PR
1RT
1IN
2
2PR
2RT
2IN
50 HIVDB
Cleland (1996) EVOLUTION of zidovudine resistance-associated genotypes in human immunodeficiency virus type 1-infected patients J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12 (1), 6-1 1e-123  
370
370RT
0 Gene fragment(s)
Clevenbergh (2002) LONG-TERM virologic outcome in patients infected with multi-nucleoside analogue resistant HIV-1 Antivir. Ther. (Lond.) (2002) In press 1e-121 24
12PR
12RT
24
12PR
12RT
100 HIVDB
Clewley (1998) A novel simian immunodeficiency virus (SIVdrl) pol sequence from the drill monkey, Mandrillus leucophaeus J. Virol. 72 (12), 10305-10309 (1998) 0 2
1PR
1RT
1IN
2
2PR
2RT
1IN
100 HIVDB
Cloyd (1990) SPECTRUM of biological properties of human immunodeficiency virus (HIV-1) isolates Virology 174 (1), 103-116 (1990) 1e-164  
2
2PR
2RT
2IN
0 Case report(s) / study subset
Coelho (2015) Transmitted Drug Resistance Among Recently Diagnosed Adults and Children in San Paulo, Brazil. AIDS Res Hum Retroviruses. 2015 Dec;31(12):1219-24. 5.1e-140 66
66PR
65RT
66
66PR
65RT
100 HIVDB
Coelho (2015) Transmission of a multi drug resistant HIV-1 by occupational exposure Unpublished 9e-62  
28
28PR
0 Case report(s) / study subset
Coelho (2017) Transmitted drug Resistence Among Adults in Sao Paulo, Brzil Unpublished 3.24e-153  
354
354PR
354RT
0 Unpublished
Coetzer (2013) Extensive Drug Resistance in HIV-Infected Cambodian Children Who Are Undetected as Failing First-Line Antiretroviral Therapy by WHO 2010 Guidelines AIDS Res. Hum. Retroviruses 29 (7), 985-992 (2013) 2.11e-150 58
58RT
58
58RT
100 HIVDB
Coleman (2011) Direct Submission Submitted (16-FEB-2011) Infectious Diseases and Pa 0  
1
1RT
0 Laboratory/experimental isolate
Collaco Veras (2011) Molecular Epidemiology of HIV-1 CRF02_AG in Cameroon and African Patients Living in Italy Unpublished 0  
52
52PR
52RT
0 ARV Rx and/or other data are N/A
Collins-Fairclough (2015) HIV Drug Resistance Surveillance among Socially Vulnerable Jamaican Men who have Sex with Men should be Prioritized for Reducing HIV Transmission Unpublished 3.29e-167  
61
61PR
61RT
0 ARV Rx and/or other data are N/A
Collins-Fairclough (2015) HIV Drug Resistance Surveillance Among Jamaican Men Who Have Sex with Men Should Be Prioritized for Reducing HIV Transmission AIDS Res. Hum. Retroviruses 31 (8), 841-844 (2015) 9.81e-168  
9
9PR
9RT
0 ARV Rx and/or other data are N/A
Collman (2000) An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol 1e-163  
1
1PR
1RT
1IN
0 Laboratory/experimental isolate
Colonno (2004) IDENTIFICATION of I50L as the Signature Atazanavir (ATV)Resistance Mutation in Treatment-Naive HIV-1Infected Patients Receiving ATV-Containing Regimens J. Infect. Dis. 189 (10), 1802-1810 (2004) 1e-59 22
22PR
22
22PR
100 HIVDB
Colson (2014) HIV infection en route to endogenization: two cases Clin. Microbiol. Infect. (2014) In press 0  
22
4PR
5RT
15IN
0 Evolution/quasispecies study
Condra (1996) GENETIC correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor J. Virol. 70 (12), 8270-8276 (1996) 1e-130 421
421PR
421
421PR
100 HIVDB
Cong (2006) THE Fitness Cost of Mutations Associated with Human Immunodeficiency Virus Type 1 Drug Resistance Is Modulated by Mutational Interactions J. Virol. 81 (6), 3037-3041 (2007) 1e-172  
4
4RT
0 Laboratory/experimental isolate
Coovadia (2008) PERSISTENT Minority K103N Mutations among Women Exposed to Single-Dose Nevirapine and Virologic Response to Nonnucleoside Reverse-Transcriptase Inhibitor-Based Therapy Clin. Infect. Dis. (2009) In press 1e-168  
99
99RT
0 Pending
Corbet (1999) ENV sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area J. Virol. 74 (1), 529-534 (2000) 1e-147 1
1PR
1RT
1IN
3
1PR
1RT
3IN
33 HIVDB
Cornelissen (1997) POL gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D J. Virol. 71 (9), 6348-6358 (1997) 1e-126 41
41PR
41RT
42
42PR
42RT
97 HIVDB
Cornelissen (2000) SPREAD of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa J. Gen. Virol. 81 (Pt 2), 515-523 (2000) 2e-86 20
20PR
20RT
21
21PR
21RT
95 HIVDB
Courgnaud (1992) GENETIC differences accounting for evolution and pathogenicity of simian immunodeficiency virus from a sooty mangabey monkey after cross-species transmission to a pig-tailed macaque J. Virol. 66 (1), 414-419 (1992) 6.88e-114 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Courgnaud (2001) CHARACTERIZATION of a novel simian immunodeficiency virus from guereza colobus monkeys (Colobus guereza) in Cameroon: a new lineage in the nonhuman primate lentivirus family J. Virol. 75 (2), 857-866 (2001) 1e-76 3
1PR
1RT
3IN
3
1PR
3RT
3IN
100 HIVDB
Courgnaud (2002) CHARACTERIZATION of a Novel Simian Immunodeficiency Virus with a vpu Gene from Greater Spot-Nosed Monkeys (Cercopithecus nictitans) Provides New Insights into Simian/Human Immunodeficiency Virus Phylogeny J. Virol. 76 (16), 8298-8309 (2002) 4e-97 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Courgnaud (2003) PARTIAL Molecular Characterization of Two Simian Immunodeficiency Viruses (SIV) from African Colobids: SIVwrc from Western Red Colobus (Piliocolobus badius) and SIVolc from Olive Colobus (Procolobus verus) J. Virol. 77 (1), 744-748 (2003) 1e-149 5
1PR
2RT
5IN
5
5RT
5IN
100 HIVDB
Courgnaud (2003) IDENTIFICATION of a New Simian Immunodeficiency Virus Lineage with a vpu Gene Present among Different Cercopithecus Monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon J. Virol. 77 (23), 12523-12534 (2003) 0 2
2PR
2RT
2IN
2
2PR
2RT
2IN
100 HIVDB
Courtney (2016) Monitoring HIV-1 Group M Subtypes in Yaounde, Cameroon Reveals Broad Genetic Diversity and a Novel CRF02_AG/F2 Infection AIDS Res. Hum. Retroviruses (2015) In press 0 109
109RT
109
109RT
100 HIVDB
Courtney (2017) Contrasting antibody responses to intrasubtype superinfection with CRF02_AG PLoS ONE 12 (3), E0173705 (2017) 7.99e-112  
798
798RT
0 New
Cousins (2014) A Comparison of Two Measures of HIV Diversity in Multi-Assay Algorithms for HIV Incidence Estimation PLoS ONE 9 (6), E101043 (2014) 0  
138
138PR
138RT
0 ARV Rx and/or other data are N/A
Cousins (2017) Population sequencing analysis of samples from the MetroMates Study Unpublished 0  
104
104PR
104RT
0 New
Couto-Fernandez (2006) PHYLOGENETIC Analysis of Brazilian HIV Type 1 Subtype D Strains: Tracing the Origin of This Subtype in Brazil AIDS Res. Hum. Retroviruses 22 (2), 207-211 (2006) 0 5
5IN
10
5PR
5RT
5IN
50 HIVDB
Crandall (1999) PARALLEL evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection Mol. Biol. Evol. 16 (3), 372-382 (1999) 1e-121  
41
41PR
0 Evolution/quasispecies study
Crandall (1999) ADVANCES in understanding the evolution of HIV AIDS 13, S39-S47 (1999) 1e-102  
49
49PR
0 Evolution/quasispecies study
Crawford (2014) Occurrence of etravirine/rilpivirine-specific resistance mutations selected by efavirenz and nevirapine in Kenyan patients with non-B HIV-1 subtypes failing antiretroviral therapy. AIDS. 2014 Jan 28;28(3):442-5. 2.98e-145 28
14PR
14RT
28
14PR
14RT
100 HIVDB
Crowell (2003) OPTIMIZATION of Oligonucleotide Ligation Assay for Detection of Drug Resistance Mutations in Non-Subtype B HIV-1 Unpublished 1e-133  
18
17PR
18RT
0 ARV Rx and/or other data are N/A
Cuevas (2015) Extremely high mutation rate of HIV-1 in vivo Unpublished 0 11
11PR
11RT
11IN
11
11PR
11RT
11IN
100 HIVDB
Cuevas (2010) Incidence of non-B subtypes of HIV-1 in Galicia, Spain: high frequency and diversity of HIV-1 among men who have sex with men Euro Surveill. 14 (47) (2009) 0 92
92PR
92RT
92
92PR
92RT
100 HIVDB
Cuevas (2009) HIV-1 transmission cluster with T215D revertant mutation among newly diagnosed patients from the Basque Country, Spain J. Acquir. Immune Defic. Syndr. 51 (1), 99-103 (20 1.18e-151 287
287PR
287RT
287
287PR
287RT
100 HIVDB
Cuevas (2010) Biological and genetic characterization of HIV-1 subtype B and non subtype-B transmitted viruses: usefulness for vaccine candidate assessment AIDS Res Hum Retroviruses. 2010 Sep;26(9):1019-25 0 25
25PR
25RT
25IN
28
28PR
28RT
28IN
89 HIVDB
Cuevas (2015) Direct Submission Submitted (13-JUL-2015) Unidad de Biologia y Varia 0  
70
70PR
70RT
40IN
0 Unpublished
Cunha (2016) Distribution of Human Immunodeficiency Virus Type 1 (HIV-1) Subtypes in North Region of Brazil: Identification of C Subtype in the State of Amazonas Unpublished 2.1e-169  
23
23RT
0 Case report(s) / study subset
Cunningham (2002) Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316. J Infect Dis. 2002 Jul 15;186(2):181-8. Epub 2002 Jun 26. 5e-92  
79
79RT
0 ARV Rx and/or other data are N/A
Cunningham (2017) Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK J. Antimicrob. Chemother. 72 (1), 227-234 (2017) 0  
70
70PR
70RT
0 Case report(s) / study subset
Currier (2006) CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response BMC Immunol. 7, 8 (2006) 3.45e-20  
36
36PR
0 Gene fragment(s)
D'arc (2015) Origin of the HIV-1 group O epidemic in western lowland gorillas Proc. Natl. Acad. Sci. U.S.A. (2015) In press 0  
7
4PR
5RT
7IN
0 Pending
D'Arrigo (2007) GP41 Sequence Variability in HIV Type 1 Non-B Subtypes Infected Patients Undergoing Enfuvirtide Pressure AIDS Res. Hum. Retroviruses 23 (10), 1296-1302 (2007) 0  
3
3PR
3RT
0 Case report(s) / study subset
D'Ettorre (2013) An HIV Type 2 Case Series in Italy: A Phylogenetic Analysis AIDS Res. Hum. R